false FY 0001069394 A0

 2025-03-30

 FSI:ENPInvestmentsLLCAndENPMendotaMember

 FSI:ENPPeruMember
 FSI:UnrelatedPartyMember

 2022-01-01

 FSI:ENPPeruMember

 2022-01-01

 FSI:ENPInvestmentsAndENPMendotaMember

 2022-01-01

 FSI:ENPPeruMember

 FSI:UnrelatedPartyMember

 FSI:FirstTermMember

 FSI:SecondTermMember

 FSI:ThirdTermMember

 FSI:FourthTermMember

 us-gaap: ShippingAndHandlingMember

 us-gaap: ShippingAndHandlingMember

 FSI:ThreePrimaryCustomersMember
 us-gaap: RevenueFromContractWithCustomerMember

 FSI:ThreePrimaryCustomersMember
 us-gaap: RevenueFromContractWithCustomerMember

 FSI:ThreePrimaryCustomersMember
 us-gaap: AccountsReceivableMember

 FSI:ThreePrimaryCustomersMember
 us-gaap: AccountsReceivableMember

 us-gaap: MachineryAndEquipmentMember

 us-gaap: OfficeEquipmentMember

 us-gaap: BuildingAndBuildingImprovementsMember

 us-gaap: AutomobilesMember

 us-gaap: TechnologyEquipmentMember

 us-gaap: BuildingAndBuildingImprovementsMember

 us-gaap: AutomobilesMember

 us-gaap: OfficeEquipmentMember

 us-gaap: MachineryAndEquipmentMember

 us-gaap: LandMember

 us-gaap: LeaseholdImprovementsMember

 us-gaap: DevelopedTechnologyRightsMember

 us-gaap: BuildingAndBuildingImprovementsMember

 us-gaap: AutomobilesMember

 us-gaap: OfficeEquipmentMember

 us-gaap: MachineryAndEquipmentMember

 us-gaap: LandMember

 us-gaap: LeaseholdImprovementsMember

 us-gaap: DevelopedTechnologyRightsMember

 FSI:LygosIncMember

 FSI:LygosIncMember

 FSI:TrioOpportunityCorpMember

 FSI:TrioOpportunityCorpMember

 us-gaap: CommonClassBMember
 FSI:TrioOpportunityCorpMember

 2019-01-31

 2024-08-31

 2024-08-01
 2024-08-31

 us-gaap: SubsequentEventMember

 2025-01-01

 2024-06-01

 2024-06-01

 2024-06-01

 FSI:NanoChemSolutionIncMember

 FSI:NanoChemSolutionIncMember
 FSI:StockYardAndBankMember

 FSI:NoncontrollingInterestsMember

 2024-08-31

 2024-08-01
 2024-08-31

 FSI:ENPPeruTwoMember

 FSI:ENPPeruTwoMember

 FSI:ENPPeruInvestmentsMember

 FSI:ENPPeruInvestmentsMember

 FSI:ENPPeruInvestmentsMember

 FSI:ENPPeruInvestmentsMember

 us-gaap: CanadaRevenueAgencyMember

 FSI:FederalAndStatedIncomeTaxMember

 us-gaap: CanadaRevenueAgencyMember

 FSI:TwoThousandThirtyTaxYearMember

 FSI:TwoThousandThirtyOneYearMember

 FSI:TwoThousandThirtyTwoYearMember

 FSI:TwoThousandThirtySevenYearMember

 FSI:TwoThousandThirtyNineYearMember

 FSI:TwoThousandFourtyYearMember

 FSI:TwoThousandFourtyOneYearMember

 FSI:TwoThousandFourtyTwoYearMember

 FSI:TwoThousandFourtyThreeYearMember

 FSI:ConsultantsMember

 FSI:ConsultantsMember

 FSI:EmployeesMember

 FSI:EmployeesMember

 us-gaap: CanadaRevenueAgencyMember

 us-gaap: CanadaRevenueAgencyMember

 FSI:WagesAndAdministrativeSalariesMember

 FSI:WagesAndAdministrativeSalariesMember

 FSI:ConsultingMember

 FSI:ConsultingMember

 us-gaap: EmployeeStockOptionMember

 us-gaap: EmployeeStockOptionMember

 FSI:ConsultantStockOptionMember

 FSI:ConsultantStockOptionMember

 us-gaap: AccountsReceivableMember
 FSI:ThreeCustomersMember

 us-gaap: AccountsReceivableMember
 FSI:ThreeCustomersMember

 FSI:EWCPMember

 FSI:BCPAMember

 FSI:OtherMember

 FSI:EWCPMember

 FSI:BCPAMember

 FSI:OtherMember

 FSI:EWCPMember

 FSI:BCPAMember

 FSI:OtherMember

 FSI:EWCPMember

 FSI:BCPAMember

 FSI:OtherMember

 country: CA

 country: CA

 FSI:UnitedStatesandAbroadMember

 FSI:UnitedStatesandAbroadMember

 country: CA

 country: CA

 country: US

 country: US

 2024-10-01

 us-gaap: SubsequentEventMember

 2025-01-01
 2025-03-31

 FSI:Segments

 united
states

 SECURITIES
AND EXCHANGE COMMISSION

 WASHINGTON,
D.C. 20549

 FORM

 ANNUAL
 REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the Fiscal Year Ended December 31, 2024

 OR

 TRANSITION
 REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 Commission
File No. 001-31540

 (Exact
name of registrant as specified in its charter)

 Alberta

 71-1630889

 (State or other jurisdiction of

 incorporation or organization)

 (Employer
 Identification No.)

 6001
 54 Ave.

 Taber,
 Alberta, Canada

 T1G
 1X4

 (Address
 of Principal Executive Office)

 Zip
 Code

 Registrant's
telephone number, including Area Code: (403) 223-2995

 Securities
registered pursuant to Section 12(b) of the Act:

 Title
 of each class

 Trading
 Symbol

 Name
 of each exchange on which registered

 Common
 Stock, $0.001 par value

 FSI

 NYSE
 American

 Securities
registered pursuant to Section 12(g) of the Act: None

by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 Yes
 No

by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

 Yes
 No

by check mark whether the registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. Yes No

by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant
to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files). Yes No

by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this
Form 10-K or any amendment to this Form 10-K.

by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer",
"smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large
 accelerated filer

 Accelerated
 filer

 Non-accelerated
 filer

 Smaller
 reporting company

 Emerging
 growth company

 If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

by check mark if the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its
internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act by the registered public accounting firm that
prepared or issued its audit report.

 If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements.

by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).

by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act): Yes No

 As
of June 30, 2024 the aggregate market value of the Company's common stock held by non-affiliates was $ 19,992,921 based on the closing
price for shares of the Company's common stock on the NYSE American for that date.

 As
of March 30, 2025, the Company had 12,647,532 issued and outstanding shares of common stock.

 Documents
incorporated by reference: None

 The
terms "Flexible", "Company", "we", "us", and "our" are used to refer to Flexible
Solutions International, Inc. and its subsidiaries, unless the context otherwise requires.

 CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS

 This
Annual Report on Form 10-K for the year ended December 31, 2024 ("Annual Report"), including the Audited Consolidated Financial
Statements, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements include, without limitation, those statements relating to development of new products, our financial condition and our ability
to increase distribution of our products. Forward-looking statements can be identified by the use of forward-looking terminology, such
as "may," "will," "should," "expect," "anticipate," "estimate,"
"continue," "plans," "intends," or other similar terminology. These forward-looking statements are
not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual
outcomes and results may differ materially from what is anticipated or forecasted in these forward-looking statements due to numerous
factors, including, but not limited to, our ability to generate or obtain sufficient working capital to continue our operations, changes
in demand for our products, the timing of customer orders and deliveries and the impact of competitive products and pricing. In addition,
such statements could be affected by general industry and market conditions and growth rates, and general domestic and international
economic conditions.

 Although
we believe that the expectations reflected in these forward-looking statements are reasonable and achievable, such statements involve
risks and uncertainties and no assurance can be given that our actual results will be consistent with these forward-looking statements.
Except as otherwise required by applicable securities laws, we undertake no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events, changed circumstances or any other reason, after the date this Annual
Report is filed with the Securities and Exchange Commission.

 PART
I

 Item
 1.

 Description
 of Business

 We
were incorporated as Flexible Solutions Ltd., a British Columbia corporation on January 26, 1991. On May 12, 1998, we merged Flexible
Solutions Ltd. into Flexible Solutions International, Inc., a Nevada corporation. In connection with this merger, we issued 7,000,000
shares of common stock to the former shareholders of Flexible Solutions Ltd. in exchange for all of the outstanding shares of Flexible
Solutions Ltd.

 In
June 2004 we purchased 52 U.S. and 139 International Patents ("IP"), as well as a 56,780 sq. ft. manufacturing plant near
Chicago, Illinois from the bankruptcy estate of Donlar Corporation ("Donlar") for $6.15 million. The IP we acquired from
Donlar relates to water-soluble chemicals ("TPAs") which prevent corrosion and scaling in water pipes used in the petroleum,
chemical, utility and mining industries. TPAs are also used to enhance fertilizers and improve crop yields and as additives for household
laundry detergents, consumer care products and pesticides. These assets are held in our wholly owned subsidiary, NanoChem Solutions Inc.
("NanoChem"), which has become our largest revenue generator.

 In
October 2018, we purchased 65% of ENP Investments, LLC, a manufacturing and distribution company active in the areas of golf, turf and
ornamental agriculture products.

 In
January 2019, we purchased 50% of a Florida based limited liability company engaged in international sales of fertilizer additives. This
purchase is accounted for as an equity accounted investment.

 In
2019, we changed our corporate domicile from Nevada to Alberta, Canada.

 In
January 2020, ENP Realty, LLC became a wholly owned subsidiary of ENP Investments, LLC and was renamed to ENP Mendota, LLC. ENP Mendota
owns a building that the Company occupies.

 In
June 2022, ENP Peru Investments, LLC became a wholly owned subsidiary with NanoChem owning 91.67% and ENP Investments, LLC owning 8.33%
of ENP Peru. In 2023, NanoChem purchased the remaining 8.33% of shares to become sole owner. ENP Peru was previously accounted for under
the equity method however, from 2022 it is consolidated into the financial statements from the date control was obtained. ENP Peru owns
a building the Company occupies.

 In
June 2023, 317 Mendota LLC ("317 Mendota") was created to purchase real estate and the Company has 80% ownership with an
unrelated party (NCI) owning the remaining 20%. The Company occupies part of the building currently owned by 317 Mendota and intends
to rent out the remaining portion of the building. For financial reporting purposes, the assets, liabilities and earnings of 317 Mendota
are consolidated into these financial statements. The NCI's ownership interest in 317 Mendota is recorded in non-controlling interests
in these consolidated financial statements.

 We
operate through a number of wholly-owned subsidiaries which are further discussed in Note 1 to the consolidated financial statements
included as part of this report. Unless otherwise indicated, all references to our business include the operations of these subsidiaries.

 Our
website is www.flexiblesolutions.com

 Our
Products

 Thermal
Polyaspartates ("TPAs")

 We
manufacture TPAs in our Peru, Illinois plant using a thermal polymerizing process. The multiple variants produced are optimized for individual
market verticals and sold for end use or through distribution.

 TPAs
for Oilfields. TPAs are used to reduce scale and corrosion in various "topside" water systems. They are used in place
of traditional phosphonate and other products when biodegradability is required by environmental regulations. We have the ability to
custom manufacture TPAs depending on the specific water conditions associated with any oil well. TPAs are also used in fracking fluids
to reduce the toxicity while maintaining equal function.

 TPAs
for the Agricultural Industry. TPAs have the ability to reduce fertilizer crystallization before, during and after application and
can also delay crystal formation between fertilizer and minerals present in the soil. Once crystallized, fertilizer and soil minerals
are not able to provide plant nourishment. As a result, in select conditions the use of TPAs either blended with fertilizer or applied
directly to crops can increase yields significantly. TPAs are designated for crop nutrient management programs and should not be confused
with crop protection and pesticides or other agricultural chemical applications. Depending on the application, TPA products are marketed
under a variety of brands including EX-10TM, AmisorbTM, LYNXTM, MAGNETTM, AmGroTM and VOLTTM. Markets of significance include corn, wheat,
soybeans, rice, potatoes, sugar beets, cotton, tomatoes, almonds and other high value per acre crops.

 TPAs
for Irrigation. The crystallization prevention ability of TPAs can also be useful in select irrigation conditions. By reducing calcium
carbonate scale propagation, TPAs can prevent early plugging of drip irrigation ports, reduce maintenance costs and lengthen the life
of equipment. TPAs compete with acid type scale removers, but have the advantage of a positive yield effect on the plant, as well as
an easier deployment formulation with liquid fertilizers when used as part of a "fertigation" program. Our TPAs for drip
irrigation scale prevention are marketed and sold through the same channels as TPAs used by the agricultural industry.

 TPAs
in Cleaning Products. TPA can replace polyacrylates in cleaning products which is valuable because TPA is biodegradable while polyacrylates
are not. In a cleaning product formulation, TPA prevents the re-deposition of dirt onto the surfaces to be cleaned allowing dirt to be
rinsed away.

 Nitrogen
Conservation Products for Agriculture. We manufacture and sell two conservation products and mixtures used for slowing nitrogen loss
from fields. One significant loss route for nitrogen fertilizer is enzymatic degradation by bacteria naturally present in soil. Our product,
SUN 27TM inhibits the bacterial action and keeps the nitrogen fertilizer available for plant growth. The second significant nitrogen
loss mechanism is de-nitrification. This is also caused by bacterial activity in soil resulting in oxygen being stripped from the fertilizer
leaving nitrogen gas. The gas can't be used by the plants and escapes into the atmosphere. Our N Savr 30TM product uses the most
effective active ingredients available to combat this cause of fertilizer loss. We sell SUN 27TM and N Savr 30TM through distributors
in North and South America under our trade names and under private labels.

 Food
and Nutritional Materials

 We
have installed custom equipment used to produce food and nutritional materials. All the ingredients we produce are custom products for
specific clients and are confidential. We anticipate that this market vertical will grow over time.

 HEATSAVR

 Our
studies indicate that approximately 70% of the energy lost from a swimming pool occurs through water evaporation. HEATSAVR is a
chemical product for use in swimming pools and spas that forms a thin, transparent layer on the water's surface. The transparent
layer slows the evaporation of water, allowing the water to retain a higher temperature for a longer period of time and thereby reducing
the energy required to maintain the desired temperature of the water. We have received reports from our commercial customers documenting
energy savings of between $2,400 and $6,000 per year when using HEATSAVR.

 In
outdoor pools, the HEATSAVR also provides convenience compared to pool blankets. It is often inconvenient to use conventional pool
blankets since a pool blanket must be removed and stored before the pool can be used. Pool blankets do not provide any energy savings
when not on the pool. Conversely, HEATSAVR eliminates the need to install, remove and store the blanket and works 24 hours a day.
In addition, the use of HEATSAVR in an indoor pool results in even greater energy savings since indoor pool locations use energy
not only to heat the pool water, but also to air condition the pool environment. By slowing the transfer of heat and water vapor from
the pool to the atmosphere of the pool enclosure, less energy is required to maintain a pool at the desired temperature and there is
a reduced load on the air-conditioning system. We also manufacture and sell products which automatically dispense HEATSAVR into
commercial size swimming pools or spas at the rate of one ounce per 400 sq. ft. of water surface per day.

 WATERSAVR

 This
product utilizes a patented variation of our HEATSAVR technology to reduce water evaporation in reservoirs, potable water storage tanks,
livestock watering ponds, aqueducts, canals and irrigation ditches. WATERSAVR may also be used for lawn and turf care and potted and
bedding plants.

 WATERSAVR
is sold in granulated form and can be applied by hand, by fully automated scheduled metering, or by an automatic dispenser.

 Tests
have indicated that WATERSAVR:

 Reduces
 daily water evaporation as much as 54%;

 Reduces
 monthly water evaporation as much as 37%;

 Is
 odorless;

 Has
 no effect on invertebrates or vertebrates;

 Has
 no anticipated effect on any current drinking water treatment processes; and

 Is
 biodegradable.

 We
have one part-time employee involved in the sales and marketing of WATERSAVR.

 Principal
Customers

 The
table below presents our revenue resulting from purchases by our major customers for the periods presented.

 Year Ended December 31,

 2024

 2023

 Company A

 $
 8,050,462

 $
 6,811,083

 Company B

 $
 8,235,394

 $
 10,260,870

 Company C

 $
 4,493,455

 $
 3,410,845

 Customers
with balances greater than 10% of our receivable balances as of each of the fiscal year ends presented are shown in the following table:

 Year Ended December 31,

 2024

 2023

 Company A

 $
 5,377,088

 $
 4,225,028

 Company B

 $
 1,866,645

 $
 2,073,813

 Company D

 $
 1,189,157

 $
 670,920
 *

 *Less
than 10% in that period

 Competition

 TPAs:
 Our TPA products have direct competition with Lanxess AG (spun out of Bayer AG) ("Lanxess"), a German manufacturer of
TPAs, which uses a patented process different from ours. We have cross-licensed each other's processes and either company can use
either process for the term of the patents involved. We believe that Lanxess has approximately the same production capacity and product
costs as we do. We believe that we can compete effectively with Lanxess by offering excellent customer service in oilfield sales, superior
distributor support in the agricultural marketplace and flexibility due to our relative size. In addition, we intend to continue to seek
market niches that are not the primary targets of Lanxess. There are other competitors based in Asia.

 Our
TPA products face indirect competition from other chemicals in every market in which we are active. For purposes of oilfield scale prevention,
phosphonates, phosphates and molibdonates provide the same effect. For crop enhancement, increased fertilizer levels can serve as a substitute
for TPAs. In irrigation scale control, acid washes are our prime competitor. Notwithstanding the above, we believe our competitive advantages
include:

 Biodegradability
 compared to competing oil field chemicals;

 Cost-effectiveness
 for crop enhancement compared to increased fertilizer use; and

 Environmental
 considerations, ease of formulation and increased crop yield opportunities in irrigation scale markets.

 HEATSAVR:
 Although we are aware of two other companies that manufacture products that compete with HEATSAVR, we believe our products are
more effective and safer. We maintain fair pricing equal to or lower than our competitors and protect our intellectual property carefully.
Our products are expected to maintain market share in the competitive pool market. HEATSAVR also competes with plastic pool blanket
products. However, we believe that HEATSAVR is more effective and convenient than pool blankets.

 WATERSAVR:
 WATERSAVR competes with solid and floating covers. We believe our WATERSAVR product is superior for the following reasons:
it is less expensive, requires little capital expenditure to deploy and can be started and stopped as water scarcity escalates or declines.
As water conservation is an important priority throughout the world, numerous researchers are working to develop solutions that may compete
with, or be superior to, WATERSAVR.

 Manufacturing

 Our
56,780 sq. ft. facility in Peru, Illinois manufactures our TPA products. Raw materials for TPA production are sourced from various manufacturers
throughout the world and we believe they are available in sufficient quantities for any increase in sales. Raw materials are, however,
derived from crude oil and are subject to price fluctuations related to world oil prices.

 Our
HEATSAVR products and dispensers are made from chemicals, plastics and other materials and parts that are readily available from
multiple suppliers. We have never experienced any shortage in the availability of raw materials and parts for these products and we do
not have any long term supply contracts for any of these items. We have these products made by outside parties without long term contracts.

 Our
WATERSAVR products are manufactured by a third party. We are not required to purchase any minimum quantity of this product.

 In
January 2020, ENP Investments, LLC acquired a 100% interest in ENP Realty, LLC and the 14,000 sq. ft. manufacturing facility in Mendota,
Illinois owned by this entity.

 Government
Regulations

 TPAs:
 In the industrial oil field and agricultural markets, we have received government approval for all TPAs currently sold.

 Nitrogen
Conservation Products: We have obtained all government approvals for the markets in which we sell these products.

 HEATSAVR:
 Chemical products for use in swimming pools are covered by a variety of governmental regulations in all countries where we sell these
products. These regulations cover packaging, labeling, and product safety. We believe our products are in compliance with these regulations.

 WATERSAVR:
 Our WATERSAVR product is subject to regulation in most countries, particularly for agricultural and drinking water uses. We
do not anticipate that governmental regulations will be an impediment to marketing WATERSAVR because the components in WATERSAVR
have historically been used in agriculture for many years for other purposes. Nevertheless, we may require county or state approval on
a case by case basis to sell WATERSAVR in the United States for agricultural and drinking water uses. We have received National
Sanitation Foundation approval for the use of WATERSAVR in drinking water in the United States.

 Proprietary
Rights

 Our
success is dependent, in part, upon our proprietary technology. We rely on a combination of patent, copyright, trademarks, trade secrets
and nondisclosure agreements to protect our proprietary technology. We hold several US patents with various expiry dates. We have applied
for additional patents in new areas of invention and may extend these patents, if granted to other jurisdictions. There can be no assurance
that our patent applications will be granted or that any issued patent will be upheld as valid or prevent the development of competitive
products, which may be equivalent to or superior to our products. We have not received any claims alleging infringement of the intellectual
property rights of others, but there can be no assurance that we may not be subject to such claims in the future.

 Research
and Development

 We
spent $329,952 during the year ended December 31, 2024 and $158,246 during year ended December 31, 2023 on research and development.

 Employees

 As
of December 31, 2024, we had 45 employees, including one officer, 17 sales and customer support personnel, and 27 manufacturing personnel.
None of our employees are represented by a labor union and we have not experienced any work stoppages to date.

 Item
 1A.

 Risk
 Factors

 This
Form 10-K contains forward-looking information based on our current expectations. Because our actual results may differ materially from
any forward-looking statements made by us, this section includes a discussion of important factors that could affect our future operations
and result in a decline in the market price of our common stock.

 We
have in the past incurred significant operating losses and may not sustain profitability in the future.

 We
have in the past experienced operating losses and negative cash flow from operations. If our revenues decline, our results of operations
and liquidity may be materially and adversely affected. If we experience slower than anticipated revenue growth or if our operating expenses
exceed our expectations, we may not be profitable. We may not remain profitable in future periods.

 Fluctuations
in our operating results may cause our stock price to decline.

 Given
the nature of the markets in which we operate, we cannot reliably predict future revenues and profitability. Changes in competitive,
market and economic conditions may cause us to adjust our operations. A high proportion of our costs are fixed, due in part to our sales,
research and development and manufacturing costs. Thus, small declines in revenue could disproportionately affect our operating results.
Factors that may affect our operating results and the market price of our common stock include:

 Demand
 for and market acceptance of our products;

 Competitive
 pressures resulting in lower selling prices;

 Adverse
 changes in the level of economic activity in regions in which we do business;

 Adverse
 changes in the oil and gas industry on which we are particularly dependent;

 in the portions of our revenue represented by various products and customers;

 Delays
 or problems in the introduction of new products;

 The
 announcement or introduction of new products, services or technological innovations by our competitors;

 Variations
 in our product mix;

 The
 timing and amount of our expenditures in anticipation of future sales;

 costs of raw materials or supplies;

 in the volume or timing of product orders; and

 Uncertainty
 in the tariff rates being charged.

 Our
operations are subject to seasonal fluctuation.

 Our
TPA business is the least seasonal, however there is a small increase in the spring related to inventory building for the crop season
in the United States and a small slowdown in December as oilfield customers run down stock in advance of year end, but otherwise, there
is little seasonal variation. We believe we are able to adequately respond to these seasonal fluctuations by reducing or increasing production
as needed. The foregoing is equally true of our nitrogen conservation products. The use of our swimming pool products increases in summer
months in most markets and results in our sales from January to June being greater than in July through December. Markets for our WATERSAVR
product are also seasonal, depending on the wet versus dry seasons in particular countries. We attempt to sell into a variety of countries
with different seasons on both sides of the equator in order to minimize seasonality.

 Interruptions
in our ability to purchase raw materials and components may adversely affect our profitability.

 We
purchase certain raw materials and components from third parties pursuant to purchase orders placed from time to time. Because we do
not have guaranteed long-term supply arrangements with our suppliers, any material interruption in our ability to purchase necessary
raw materials or components could have a material adverse effect on our business, financial condition and results of operations.

 Our
WATERSAVR product has not proven to be a revenue producing product and we may never recoup the cost associated with its development.

 The
marketing efforts of our WATERSAVR product may result in continued losses. We introduced our WATERSAVR product in June 2002
and, to date, we have delivered quantities for testing by potential customers, but only a few customers have ordered the product for
commercial use. This product can achieve success only if it is ordered in substantial quantities by commercial customers who have determined
that the water saving benefits of the product exceed the costs of purchase and deployment of the product. We can offer no assurance that
we will receive sufficient orders of this product to achieve profits or cover the expenses incurred to manufacture and market this product.
We have received National Sanitation Foundation approval for the use of WATERSAVR in drinking water in the United States. Nevertheless,
we may require county or state approval on a case by case basis. We expect to spend $50,000 on the marketing and production of our WATERSAVR
product in fiscal 2025.

 If
we do not introduce new products in a timely manner, our products could become obsolete and our operating results would suffer.

 Without
the timely introduction of new products and enhancements, our products could become obsolete over time, in which case our revenue and
operating results would suffer. The success of our new product offerings will depend upon several factors, including our ability to:

 Accurately
 anticipate customer needs;

 Innovate
 and develop new products and applications;

 Successfully
 commercialize new products in a timely manner;

 Price
 our products competitively and manufacture and deliver our products in sufficient volumes and on time; and

 Differentiate
 our products from our competitors' products.

 In
developing any new product, we may be required to make a substantial investment before we can determine the commercial viability of the
new product. If we fail to accurately foresee our customers' needs and future activities, we may invest heavily in research and
development of products that do not lead to significant revenues.

 We
are dependent upon certain customers.

 Among
our current customers, we have identified three that are sizable enough that the loss of any one would be significant. Any loss of one
or more of these customers could result in a substantial reduction in our revenues. See "Principal Customers" in Item 1 of
this report for further details.

 Economic,
political and other risks associated with international sales and operations could adversely affect our sales.

 Revenues
from shipments made outside of the United States accounted for approximately 24% of our revenues in the year ended December 31, 2024,
21% in the year ended December 31, 2023 and 20% in the year ended December 31, 2022. Since we sell our products worldwide, our business
is subject to risks associated with doing business internationally. We anticipate that revenues from international operations will continue
to represent a sizable portion of our total revenue. Accordingly, our future results could be harmed by a variety of factors, including:

 in foreign currency exchange rates;

 in a country's or region's political or economic conditions, particularly in developing or emerging markets;

 Longer
 payment cycles of foreign customers and difficulty of collecting receivables in foreign jurisdictions;

 Trade
 protection measures and import or export licensing requirements;

 Differing
 tax laws and changes in those laws;

 Difficulty
 in staffing and managing widespread operations;

 Differing
 laws regarding protection of intellectual property; and

 Differing
 regulatory requirements and changes in those requirements.

 We
are subject to credit risk and may be subject to substantial write-offs if one or more of our significant customers default on their
payment obligations to us.

 We
currently allow our major customers between 30 and 90 days to pay for each sale. This practice, while customary, presents an accounts
receivable write-off risk if one or more of our significant customers defaulted on their payment obligations to us. Any such write-off,
if substantial, would have a material adverse effect on our business and results of operations. See above principal customer information.

 Our
products can be hazardous if not handled, stored and used properly; litigation related to the handling, storage and safety of our products
would have a material adverse effect on our business and results of operations.

 Some
of our products are flammable and must be stored properly to avoid fire risk. Additionally, some of our products may cause irritation
to a person's eyes if they are exposed to the concentrated product. Although we label our products to warn of such risks, our sales
could be reduced if our products were considered dangerous to use or if they are implicated in causing personal injury or property damage.
We are not currently aware of any circumstances in which our products have caused harm or property damage to consumers. Nevertheless,
litigation regarding the handling, storage and safety of our products would have a material adverse effect on our business and results
of operations.

 Our
failure to comply with environmental regulations may create significant environmental liabilities and force us to modify our manufacturing
processes.

 We
are subject to various federal, state and local environmental laws, ordinances and regulations relating to the use, storage, handling
and disposal of chemicals. Under such laws, we may become liable for the costs of removal or remediation of these substances that have
been used by our consumers or in our operations. Such laws may impose liability without regard to whether we knew of, or caused, the
release of such substances. Any failure by us to comply with present or future regulations could subject us to substantial fines, suspension
of production, alteration of manufacturing processes or cessation of operations, any of which could have a material adverse effect on
our business, financial condition and results of operations.

 Our
failure to protect our intellectual property could impair our competitive position.

 While
we own certain patents and trademarks, some aspects of our business cannot be protected by patents or trademarks. Accordingly, in these
areas there are few legal barriers that prevent potential competitors from copying certain of our products, processes and technologies
or from otherwise entering into operations in direct competition with us.

 Our
products may infringe on the intellectual property rights of others, and resulting claims against us could be costly and prevent us from
making or selling certain products.

 Third
parties may seek to claim that our products and operations infringe on their patent s or other intellectual property rights. We
may incur significant expense in any legal proceedings to protect our proprietary rights or to defend infringement claims by third parties.
In addition, claims of third parties against us could result in awards of substantial damages or court orders that could effectively
prevent us from making, using or selling our products in the United States or internationally.

 A
product liability claim for damages could materially and adversely affect our financial condition and results of operations.

 Our
business exposes us to potential product liability risks. There are many factors beyond our control that could lead to liability claims,
including the failure of our products to work properly and the chance that consumers will use our products incorrectly or for purposes
for which they were not intended. There can be no assurance that the amount of product liability insurance that we carry will be sufficient
to protect us from product liability claims. A product liability claim in excess of the amount of insurance we carry could have a material
adverse effect on our business, financial condition and results of operations.

 Our
ongoing success is dependent upon the continued availability of certain key employees.

 Our
business would be adversely affected if the services of Daniel B. O'Brien ceased to be available to us since we currently do not
have any other employee with an equivalent level of expertise in and knowledge of our industry. If Mr. O'Brien no longer served
as our President and Chief Executive Officer, we would have to recruit one or more new executives, with no real assurance that we would
be able to engage a replacement executive with the required skills on satisfactory terms. The market for skilled employees is highly
competitive, especially for employees in the fields in which we operate. While our compensation programs are intended to attract and
retain qualified employees, there can be no assurance that we will be able to retain the services of all our key employees or a sufficient
number to execute our plans, nor can there be any assurances that we will be able to continue to attract new employees as required.

 Item
 1B.

 Unresolved
 Staff Comments.

 Not

 Item
 1C.

 Cybersecurity.

 Companies
such as ours face a variety of risks, including financial reporting, legal, credit, liquidity, operational, health, safety and cybersecurity
risks. The Board believes an effective risk management system will (1) identify the material risks that we face in a timely manner, (2)
communicate necessary information with respect to material risks to senior executives and, as appropriate, to our directors (3) implement
or oversee implementation of appropriate and responsive risk management and mitigation strategies consistent with our risk profile, and
(4) integrate risk management into our decision-making.

 Our
Board oversees risk management after receiving briefings from advisors and also based on its own analysis and conclusions regarding the
adequacy of our risk management processes. The Board continuously evaluates and manages material risks including geopolitical and enterprise
risks, financial risks, environmental risks, health and safety risks and cybersecurity risks.

 George
Murray, our Operations Manager, is responsible for assessing and managing cybersecurity risks. Mr. Murray is experienced in assessing
and managing cybersecurity risks due to his direct oversight of our internet and digital communications contractors.

 To
date we have not experienced any cybersecurity threats and any risks from cybersecurity threats have not materially affected, and are
not reasonably likely to materially affect, our business strategy, results of operations, or financial condition.

 Item
 2.

 Properties.

 We
own a 61,200 sq. ft. facility and a 56,780 sq. ft. facility in Peru, Illinois along with a 14,000 sq. ft facility in Mendota, Illinois
which is used to manufacture our TPA line of products. In 2017, we purchased a 3,000 sq ft building on 1 acre of land in Taber, Alberta.
In 2023, the Company purchased an 80% share in 317 Mendota, a real estate company that was set up to purchase a manufacturing building
in Mendota, IL. ENP Investments now occupies part of this space.

 Item
 3.

 Legal
 Proceedings.

 None.

 Item
 4.

 Mine
 Safety Disclosures.

 Not

 PART
II

 Item
 5.

 Market
 for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchase of Equity Securities.

 Our
common stock is traded on the NYSE American under the symbol "FSI".

 As
of March 30, 2025, we had approximately 3,400 shareholders.

 The
Company declared a special dividend of $0.10 per share on April 23, 2024, paid on May 16, 2024 to shareholders of record on April 30,
2024.

 The
Company declared a special dividend of $0.05 per share on April 14, 2023, paid on May 16, 2023 to shareholders of record on April 28,
2023.

 None
of our officers or directors, nor any of our principal shareholders purchased, on our behalf, any shares of our common stock from third
parties either in a private transaction or as a result of purchases in the open market during the years ended December 31, 2024 and 2023.

 As
of March 30, 2025, we had 12,647,532 outstanding shares of common stock. The following table lists additional shares of our common stock,
including shares issuable upon the exercise of options which have not yet vested, which may be issued as of March 30, 2025:

 Number

 Note

 Of Shares

 Reference

 Shares issuable upon exercise of options granted to our officers, directors, employees,
 consultants, and third parties

 1,708,000

 A

 A.
Options are exercisable at prices ranging from $2.00 to $4.05 per share. See Item 11 of this report for more information concerning these
options.

 Item
 6.

 [Reserved]

 Not

 Item
 7.

 Management's
 Discussion and Analysis of Financial Condition and Results of Operations.

 Results
of Operations

 We
have three product lines.

 The
first is a chemical ("EWCP") used in swimming pools and spas. The product forms a thin, transparent layer on the water's
surface. The transparent layer slows the evaporation of water, allowing the water to retain a higher temperature for a longer period
of time thereby reducing the energy required to maintain the desired temperature of the water. A modified version of EWCP can also be
used in reservoirs, potable water storage tanks, livestock watering pods, canals, and irrigation ditches for the purpose of reducing
evaporation.

 The
second product, biodegradable polymers ("TPAs"), is used by the petroleum, chemical, utility and mining industries to prevent
corrosion and scaling in water piping. TPAs can also be used to increase biodegradability in detergents and in the agriculture industry
to increase crop yields by enhancing fertilizer uptake.

 The
third product line is nitrogen conservation products used for the agriculture industry. These products decrease the loss of nitrogen
fertilizer after initial application and allows less fertilizer to be used. These products are made and sold by the Company's TPA
division.

 The
Company also manufactures food grade products that are made and sold by the TPA division.

 Material
changes in the line items in our Statement of Income and Comprehensive Income for the year ended December 31, 2024 as compared to the
same period last year, are discussed below:

 Item

 Increase
 (I) or Decrease (D)

 Reason

 Sales

 EWCP
 products

 I

customer orders.

 TPA
 products

 D

 Decreased
 customer orders.

 Gross
 profit

 I

 Raw
 material costs declined to catch up with customer price reductions already in place.

 Insurance

 I

 Prior
 year increase in assets and in sales resulted in higher insurance costs.

 Office
 and Miscellaneous

 I

 Increase
 in property tax associated with more properties along with various other one time costs.

 Consulting

 I

 reliance on consultants instead of full time employees.

 Professional
 fees

 I

 Increase
in accounting fees related to tax filings and increase in audit fees related to growth of the Company.

 Research

 I

 New
product development.

 Utilities

 I

 Addition
of real estate not yet rented out.

 Investor
 relations

 D

 Reduced
shares traded and filings required in 2023 did not reoccur in 2024.

 Currency
 exchange

 I

 Currency
 exchange increased as a result of movements in the US / Canadian dollar exchange rate and its effects on US dollar cash balances
 and US dollar payables held by the Company's Canadian subsidiaries.

 Lease
 expense

 D

 Termination
 of lease in Naperville, IL reduced costs.

 Loss
 on lease termination

 I

 One
 time cost incurred terminating lease in Naperville, IL.

 Interest
 income

 I

 interest rates combined with increase in term deposits.

 Gain
 on investment

 D

 Sale
 of 30.1% of Florida based LLC reduced our Company's portion of the profits.

 Loss
 on sale of investment

 I

 One
time loss on the sale of 30.1 % of Florida based LLC.

 Interest
 expense

 I

 debt resulted in increased interest expense.

 Income tax expense

 I

 One time adjustments to income tax accruals in 2023 did not occur again in 2024.

 The
factors that will most significantly affect future operating results will be:

 The
 sale price of crude oil which is used in the manufacture of aspartic acid we import from China. Aspartic acid is a key ingredient
 in our TPA product. If tariffs increase and if relief is not available, some customers may experience price increases;

 Activity
 in the oil and gas industry, as we sell our TPA product to oil and gas companies; and

 Drought
 conditions, since we also sell our TPA product to farmers.

 Other
than the foregoing we do not know of any trends, events or uncertainties that have had, or are reasonably expected to have, a material
impact on our revenues or expenses.

 Capital
Resources and Liquidity

 Our
sources and (uses) of cash for the years ended December 31, 2024 and 2023 are shown below:

 2024

 2023

 Cash provided by operating activities

 $
 5,568,346

 $
 6,116,171

 Sale of investment

 2,000,000

 -

 Purchase of investments

 -

 (470,000
)

 Redemption of investments

 -

 Distributions received from equity investments

 510,710

 201,034

 Non-Controlling Interest of 317 Mendota LLC

 -

 Proceeds from sale of asset

 -

 5,411

 Purchases of property and equipment

 (4,964,736
)

 (4,990,675
)

 Advances (repayment) of line of credit

 241,680

 (1,008,112
)

 Repayment of long term debt

 (1,517,500
)

 (725,823
)

 Proceeds of long term debt

 2,162,412

 2,686,682

 Dividends paid

 (1,255,053
)

 (626,777
)

 Distributions to non-controlling interest

 (794,722
)

 (719,439
)

 Shares issued upon exercise of stock options

 184,850

 13,600

 Effects of foreign exchange rate changes on cash

 We
have sufficient cash resources to meets our future commitments and cash flow requirements for the coming year. As of December 31, 2024,
our working capital was $22,714,190 (2023 - $20,172,833) and we have no substantial commitments or capital requirements that require
significant outlays of cash over the coming fiscal year.

 Other
than as disclosed above, we do not know of any trends, demands, commitments, events or uncertainties that will result in, or that are
reasonable likely to result in, our liquidity increasing or decreasing in any material way.

 Other
than as disclosed above, we do not know of any significant changes in our expected sources and uses of cash.

 We
do not have any commitments or arrangements from any person to provide us with any equity capital.

 Critical
Accounting Policies and Estimates

 Allowances
for Doubtful Accounts Receivable. We evaluate our accounts receivable to determine if they will ultimately be collected. This evaluation
includes significant judgments and estimates, including an analysis of receivables aging and a review of large accounts. If, for example,
the financial condition of a customer deteriorates resulting in an impairment of its ability to pay or a pattern of late payment develops,
an allowance may be required.

 Provisions
for Inventory Obsolescence. We may need to record a provision for estimated obsolescence and shrinkage of inventory. Our estimates
consider the cost of inventory, the estimated market value, the shelf life of the inventory and our historical experience. If there are
changes to these estimates, provisions for inventory obsolescence may be necessary.

 Valuation
of Goodwill and Intangible Assets. We review goodwill and intangible assets to determine if there are qualitative factors which exist
which may indicate that the carrying value exceeds the fair value. Our estimates are based upon an assessment of market conditions and
expected future cash flows to be generated by the reporting units and related assets. If factors exist which indicate that the carrying
value exceeds the fair value, an impairment charge against the goodwill and intangible assets could be required.

 Useful
Lives of Property, Equipment and Leaseholds and Intangible Assets. We amortize and depreciate our property, equipment and leaseholds
and intangible assets based on their estimated useful lives. We estimate the expected useful lives based on the expected term over which
the asset is expected to continue to generate economic benefit for our company. If there are differences between the expected useful
lives and the actual useful lives of the asset, impairment of property, equipment and leaseholds or intangible assets could be necessary.

 Revenue
Recognition. We follow a five-step model for revenue recognition. The five steps are: (1) identification of the contract(s) with
the customer, (2) identification of the performance obligation(s) in the contract(s), (3) determination of the transaction price, (4)
allocation of the transaction price to the performance obligation, and (5) recognition of revenue when (or as) the performance obligation
is satisfied. We fulfill our performance obligations when control of product transfers to the customer, which is generally at the time
the product is shipped since risk of loss is transferred to the purchaser upon delivery to the carrier. For shipments which are free on board (F.O.B).
shipping point, we have elected to account for shipping and handling activities as a fulfillment cost rather than as an additional promised
service and performance obligation.

 Stock
Based Compensation The fair value of share-based payments are subject to the limitations of the Black-Scholes option pricing model
that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Since the Black-Scholes option pricing model relies on highly subjective assumptions, any changes to these inputs
can significantly impact the estimated value.

Taxes Tax interpretations, regulations and legislation in the various jurisdictions in which the Company operates are subject to
change and interpretation. As such, income taxes are subject to measurement uncertainty. Assessing the recoverability of deferred tax
assets requires the Company to make estimates related to the expectations of future taxable income and the application of existing tax
laws. To the extent that future taxable income differs significantly from estimates, the ability of the Company to realize deferred tax
assets could be impacted.

 Privately
Held Equity Investments The recoverability of privately held equity investments requires management to make certain assumptions and
estimates. Changes in these assumptions and estimates could result in materially different results.

 See
Note 2 to the consolidated financial statements included as part of this report for a description of our significant accounting policies.

 Recent
Accounting Pronouncements

 We
have evaluated recent accounting pronouncements issued since January 1, 2024 and determined that the adoption of these recent accounting
pronouncements will not have a material effect on our consolidated financial statements.

 Item
 7A.

 Quantitative
 and Qualitative Disclosures About Market Risk.

 Not

 Item
 8.

 Financial
 Statements and Supplementary Data.

SOLUTIONS INTERNATIONAL, INC. AND SUBSIDIARIES

TO CONSOLIDATED FINANCIAL STATEMENTS

 Page

 Report of Independent Registered Public Accounting Firm, Assure CPA, LLC (PCAOB ID NO: 444)

 Report of Independent Registered Public Accounting Firm, Smythe LLP (PCAOB ID NO: 995)

 Consolidated Balance Sheets as of December 31, 2024 and 2023

 Consolidated Statements of Income and Comprehensive Income for the Years Ended December 31, 2024 and 2023

 Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023

 Consolidated Statements of Stockholders' Equity for the Years Ended December 31, 2024 and 2023

 Notes to Consolidated Financial Statements

 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 To
the shareholders and the board of directors of Flexible Solutions International Inc.

 Opinion
on the Financial Statements

 We
have audited the accompanying consolidated balance sheet of Flexible Solutions International Inc. ("the Company") as of December
31, 2024 and the related consolidated statements of income and comprehensive income, stockholders' equity and cash flows for the
year then ended, and the related notes (collectively referred to as the "consolidated financial statements"). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2024 and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally
accepted in the United States of America.

 Basis
for Opinion

 These
financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing
an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 Our
audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due
to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audit provides a reasonable basis for our opinion.

 Critical
Audit Matter

 The
critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that
was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material
to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication
of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are
not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or
disclosures to which it relates.

 Uncertain
Tax Positions

 As
described in Note 12 to the consolidated financial statements, the Company has an income taxes payable balance associated with uncertain
tax positions, including interest and penalties, of approximately $3.0 million as of December 31, 2024. The Company recognizes uncertain
tax positions that it believes has a greater than 50% likelihood of being sustained upon challenge by a tax authority. The evaluation
of this liability requires significant judgment and involves complex tax regulations, interpretations, and estimates. Given the complexity
and subjectivity of these considerations, auditing the uncertain tax position required a high degree of auditor judgment.

 Addressing
the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated
financial statements. Our audit procedures related to the Company's uncertain tax position included, among others:

 Evaluating
 management's assessment of the technical merits of the tax position, including reviewing
 relevant tax laws.

 Assessing
 the adequacy of the Company's disclosures regarding the uncertain tax position and
 its impact on the financial statements.

 Evaluating
 the reasonableness of management's conclusions, including the probability of recognition
 and measurement of the liability.

 Testing
 the completeness and accuracy of the underlying data used in management's assessment.

 /s/ Assure
CPA, LLC

 We
have served as the Company's auditor since 2024.

 Spokane,
Washington

 PCAOB
ID: 444

 March

 F- 1

 Report
of Independent Registered Public Accounting Firm

 To
the Stockholders and the Board of Directors of Flexible Solutions International, Inc.

 Opinion
on the Consolidated Financial Statements

 We
have audited the accompanying consolidated financial statements of Flexible Solutions International, Inc. and its subsidiaries (the "Company")
which comprise the consolidated balance sheet as of December 31, 2023, and the related consolidated statement of income and comprehensive
income, cash flows and stockholders' equity for the year then ended, and the related notes (collectively referred to as the "consolidated
financial statements").

 In
our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the
Company as of December 31, 2023, and the consolidated results of its operations and its consolidated cash flows for the year then ended,
in conformity with accounting principles generally accepted in the United States of America.

 Basis
for Opinion

 These
consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion
on the Company's consolidated financial statements based on our audit. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.

 We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing
an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 Our
audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due
to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audit provides a reasonable basis for our opinion.

 SMYTHE
LLP | smythecpa.com

 VANCOUVER

 1700–475
Howe St

 Vancouver,
BC V6C 2B3

 T: 604 687 1231

 F:
604 688 4675

 LANGLEY

 600–19933
88 Ave

 Langley,
BC V2Y 4K5

 T: 604 282 3600

 F:
604 357 1376

 NANAIMO

 201–1825
Bowen Rd

 Nanaimo, BC V9S 1H1

 T: 250 755 2111

 F:
250 984 0886

 F- 2

 Critical
Audit Matter

 The
critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that
was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material
to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication
of this critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we
are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts
or disclosures to which it relates.

 Valuation
of inventory

 At
December 31, 2023, the Company's inventory balance was $11,134,889. As discussed in Note 2 to the consolidated financial statements,
the Company records inventory at the lower of cost on a first-in, first-out or weighted average basis and net realizable value. To determine
inventory valuation, management conducts regular reviews of overhead costs and the calculation to allocate these expenditures to inventory
 cost.

 We
identified the assessment of valuation of inventory as a critical audit matter. Auditing management's inventory valuation involved
significant judgment because the estimates are based on several factors. In particular, in estimating inventory cost inputs, management
developed assumptions such as the allocation of overhead expenditures to inventory cost.

 The
primary procedures we performed to address this critical audit matter included:

 Obtained an understanding and reviewed the appropriateness
of the Company's costing of inventory, including the allocation of overhead costs to inventory.

 Performed substantive procedures over the inputs of costing
of inventory, including overhead allocation by agreeing inputs to third party source documentation.

 Tested management's allocation of overhead costs between
inventory products by assessing the appropriateness of the allocation method and recalculated the formula used to determine computational
accuracy.

 Tested the reliability of reports used by management in inventory
costing by agreeing the report inputs to underlying records.

 Performed observations of inventory held at year-end for any
signs of obsolescence and held discussions with management and operational personnel to identify any slow-moving inventory.

 Chartered
Professional Accountants

 Vancouver,
Canada

 April
1, 2024

 We
served as the Company's auditor from 2019 to 2024.

 SMYTHE
LLP | smythecpa.com

 VANCOUVER

 1700–475
Howe St

 Vancouver,
BC V6C 2B3

 T: 604 687 1231

 F:
604 688 4675

 LANGLEY

 600–19933
88 Ave

 Langley,
BC V2Y 4K5

 T: 604 282 3600

 F:
604 357 1376

 NANAIMO

 201–1825
Bowen Rd

 Nanaimo, BC V9S 1H1

 T: 250 755 2111

 F:
250 984 0886

 F- 3

Balance Sheets

 As
at December 31

 (U.S.

 December 31, 2024

 December 31, 2023

 Assets

 Current

 Cash

 $
 7,631,055

 $
 5,017,583

 Term deposits (Note 2)

 2,400,916

 2,690,241

 Accounts receivable, net (Note 4)

 11,696,098

 9,843,056

 Inventories (Note 5)

 10,890,195

 11,134,889

 Prepaid expenses and deposits

 1,957,593

 1,540,923

 Total current assets

 34,575,857

 30,226,692

 Property, equipment and leaseholds, net (Note 6)

 17,146,184

 13,171,787

 Right of use assets (Note 3)

 -

 115,293

 Intangible assets (Note 7)

 2,120,000

 2,280,000

 Long term deposits (Note 8)

 167,882

 824,254

 Investments (Note 9)

 3,424,381

 6,033,960

 Goodwill (Note 7)

 2,534,275

 2,534,275

 Deferred tax asset (Note 12)

 -

 284,794

 Total Assets

 $
 59,968,579

 $
 55,471,055

 Liabilities

 Current

 Accounts payable

 $
 2,049,425

 $
 1,984,592

 Accrued liabilities

 403,157

 284,131

 Deferred revenue

 78,655

 148,292

 Income taxes payable

 5,137,290

 4,485,213

 Short term line of credit (Note 10)

 2,052,159

 1,810,479

 Current portion of lease liability (Note 3)

 -

 59,520

 Current portion of long term debt (Note 11)

 2,140,981

 1,281,632

 Total current liabilities

 11,861,667

 10,053,859

 Lease liability (Note 3)

 -

 55,773

 Net deferred income tax liability (Note 12)

 122,019

 260,047

 Long term debt (Note 11)

 6,618,867

 6,833,304

 Total Liabilities

 18,602,553

 17,202,983

 Commitments and Contingencies (Notes 9 and 10)

 -

 -

 Stockholders' Equity

 Capital stock (Note 15)

 Authorized: 50,000,000 common shares with a par value of $ 0.001 each; 1,000,000 preferred shares with a par value of $ 0.01 each

 Issued and outstanding:

 12,515,532 (December 31, 2023: 12,435,532) common shares

 12,516

 12,436

 Common
 stock, value

 12,516

 12,436

 Capital in excess of par value

 18,789,915

 17,932,015

 Accumulated other comprehensive loss

 ( 606,986
)

 ( 795,146
)

 Accumulated earnings

 19,836,527

 18,053,051

 Total stockholders' equity – controlling interest

 38,031,972

 35,202,356

 Non-controlling interests (Note 16)

 3,334,054

 3,065,716

 Total Stockholders' Equity

 41,366,026

 38,268,072

 Total Liabilities and Stockholders' Equity

 $
 59,968,579

 $
 55,471,055

 See
Notes to Consolidated Financial Statements.

 F- 4

Statements of Income and Comprehensive Income

 For
the Years Ended December 31

 (U.S.

 2024

 2023

 Sales

 $
 38,234,860

 $
 38,324,806

 Cost of sales (Note 6 & 7)

 24,994,961

 27,881,721

 Gross profit

 13,239,899

 10,443,085

 Operating expenses

 Wages

 2,504,523

 2,659,654

 Administrative salaries and benefits

 1,238,702

 1,205,007

 Insurance

 958,109

 861,501

 Office and miscellaneous

 805,307

 512,896

 Consulting

 473,925

 324,327

 Research

 329,952

 158,246

 Professional fees

 324,462

 238,466

 Utilities

 259,972

 123,475

 Travel

 227,837

 264,563

 Advertising and promotion

 218,269

 194,308

 Investor relations and transfer agent fee

 199,863

 222,650

 Lease expense

 72,891

 97,806

 Telecommunications

 57,970

 55,093

 Shipping

 29,408

 24,060

 Commissions

 28,093

 35,623

 Currency exchange

 ( 4,790
)

 ( 37,632
)

 Total operating expenses

 7,724,493

 6,940,043

 Operating income

 5,515,406

 3,503,042

 Non-operating income (expense)

 Gain on investments (Note 9)

 245,631

 505,065

 Loss on sale of investment (Note 9)

 ( 353,076
)

 -

 Loss on lease termination

 ( 41,350
)

 -

 Interest expense

 ( 610,265
)

 ( 498,666
)

 Interest income

 196,454

 113,809

 Total non-operating income (expenses)

 ( 562,606
)

 120,208

 Income before income tax

 4,952,800

 3,623,250

 Income taxes (Note 12)

 Deferred income tax (expense) benefit

 ( 146,767
)

 250,917

 Current income tax expense

 ( 704,444
)

 ( 118,182
)

 Net income for the year

 4,101,589

 3,755,985

 Net income attributable to non-controlling interests

 ( 1,063,060
)

 ( 980,121
)

 Net income attributable to controlling interest

 $
 3,038,529

 $
 2,775,864

 Income per share (basic and diluted) (Note 13)

 $
 0.24

 $
 0.22

 Weighted average number of common shares (basic)

 12,454,957

 12,434,886

 Weighted average number of common shares (diluted)

 12,680,668

 12,489,467

 Other comprehensive income:

 Net income

 $
 4,101,589

 $
 3,755,985

 Unrealized gain (loss) on foreign currency transactions

 Total comprehensive income

 4,289,749

 3,766,638

 Comprehensive income – non-controlling interest

 ( 1,063,060
)

 ( 980,121
)

 Comprehensive income attributable to controlling interest

 $
 3,226,689

 $
 2,786,517

 See
Notes to Consolidated Financial Statements.

 F- 5

Statements of Cash Flows

 For
Years Ended December 31

 (U.S.

 2024

 2023

 Operating activities

 Net income for the year

 $
 4,101,589

 $
 3,755,985

 Adjustments to reconcile net income to net cash:

 Stock based compensation

 Depreciation and amortization

 1,957,476

 1,686,319

 Gain on investments

 ( 245,631
)

 ( 505,065
)

 Loss on sale of investment

 353,076

 -

 Gain on sale of asset

 -

 ( 4,589
)

 Deferred income tax expense (recovery)

 146,767

 ( 250,917
)

 Changes in assets and liabilities:

 Accounts receivable

 ( 1,853,042
)

 ( 393,199
)

 Inventories

 244,694

 3,284,541

 Prepaid expenses and deposits

 ( 416,670
)

 ( 1,230,626
)

 Long term deposits

 ( 159,342
)

 ( 815,714
)

 Accounts payable

 64,833

 1,110,689

 Accrued liabilities

 119,026

 ( 675,725

)

 Income taxes payable

 652,077

 ( 1,137
)

 Deferred revenue

 ( 69,637
)

 ( 239,471
)

 Cash provided by operating activities

 5,568,346

 6,116,171

 Investing activities

 Sale of investment

 2,000,000

 -

 Distributions received from equity investments

 510,710

 201,034

 Proceeds from sale of asset

 -

 5,411

 Purchase of property and equipment

 ( 4,964,736
)

 ( 4,990,675
)

 Purchase of investments

 -

 ( 470,000
)

 Redemption of investments

 -

 Non-controlling interest of 317 Mendota

 -

 Cash used in investing activities

 ( 2,454,026
)

 ( 4,854,230
)

 Financing activities

 Advance (repayment) of line of credit

 241,680

 ( 1,008,112
)

 Repayment of long term debt

 ( 1,517,500
)

 ( 725,823
)

 Proceeds of long term debt

 2,162,412

 2,686,682

 Dividends paid

 ( 1,255,053
)

 ( 626,777
)

 Distribution to non-controlling interest

 ( 794,722
)

 ( 719,439
)

 Shares issued upon exercise of stock options

 184,850

 13,600

 Cash provided by (used in) financing activities

 ( 978,333
)

 ( 379,869
)

 Effect of foreign exchange rate changes on cash

 Increase in cash and term deposits

 2,324,147

 892,725

 Cash and term deposits, beginning of year

 7,707,824

 6,815,099

 Cash and term deposits, end of year

 $
 10,031,971

 $
 7,707,824

 Cash and term deposits is comprised of:

 Cash

 $
 7,631,055

 $
 5,017,583

 Term deposits

 2,400,916

 2,690,241

 Cash and cash equivalents, ending

 $
 10,031,971

 $
 7,707,824

 Supplemental disclosure of cash flow information:

 Income taxes paid

 $
 52,367

 $
 119,319

 Interest paid

 610,625

 498,666

 See
Notes to Consolidated Financial Statements.

 F- 6

Statements of Stockholders' Equity

 For
the Years Ended December 31, 2024 and 2023

 (U.S.

 Shares

 Capital Stock

 Capital
 in
 Excess
 of
 Par
 Value

 Accumulated
 Earnings

 Accumulated
 Other
 Comprehensive
 (Loss)

 Total

 Non-
 Controlling
 Interests

 Total
 Stockholders'
 Equity

 Balance December 31, 2022

 12,426,260

 $
 12,426

 $
 17,523,345

 $
 15,903,964

 $
 ( 805,799
)

 $
 32,633,936

 $
 2,605,034

 $
 35,238,970

 Translation adjustment

 —

 —

 —

 —

 —

 Dividends paid

 —

 —

 —

 ( 626,777
)

 —

 ( 626,777
)

 —

 ( 626,777
)

 Non-controlling interest of 317 Mendota LLC

 —

 —

 —

 —

 —

 —

 Net income

 —

 —

 —

 2,775,864

 —

 2,775,864

 980,121

 3,755,985

 Shares issued upon exercise of stock options

 9,272

 13,590

 —

 —

 13,600

 —

 13,600

 Distributions to noncontrolling interests

 —

 —

 —

 —

 —

 —

 ( 719,439
)

 ( 719,439
)

 Stock-based compensation

 —

 —

 —

 —

 —

 Balance December 31, 2023

 12,435,532

 $
 12,436

 $
 17,932,015

 $
 18,053,051

 $
 ( 795,146
)

 $
 35,202,356

 $
 3,065,716

 $
 38,268,072

 Balance

 12,435,532

 $
 12,436

 $
 17,932,015

 $
 18,053,051

 $
 ( 795,146
)

 $
 35,202,356

 $
 3,065,716

 $
 38,268,072

 Translation adjustment

 —

 —

 —

 —

 —

 Dividends paid

 —

 —

 —

 ( 1,255,053
)

 —

 ( 1,255,053
)

 —

 ( 1,255,053
)

 Net income

 —

 —

 —

 3,038,529

 —

 3,038,529

 1,063,060

 4,101,589

 Common shares issued upon exercise of stock options

 80,000

 184,770

 —

 —

 184,850

 —

 184,850

 Distributions to noncontrolling interests

 —

 —

 —

 —

 —

 —

 ( 794,722
)

 ( 794,722
)

 Stock-based compensation

 —

 —

 —

 —

 —

 Balance December 31, 2024

 12,515,532

 $
 12,516

 $
 18,789,915

 $
 19,836,527

 $
 ( 606,986
)

 $
 38,031,972

 $
 3,334,054

 $
 41,366,026

 Balance

 12,515,532

 $
 12,516

 $
 18,789,915

 $
 19,836,527

 $
 ( 606,986
)

 $
 38,031,972

 $
 3,334,054

 $
 41,366,026

 See
Notes to Consolidated Financial Statements.

 F- 7

 NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

 December
31, 2024 and 2023

 (U.S.

 1.
 BASIS OF PRESENTATION

 These
consolidated financial statements ("consolidated financial statements") include the accounts of Flexible Solutions International,
Inc. (the "Company"), its wholly-owned subsidiaries Flexible Fermentation Ltd., NanoChem Solutions Inc. ("NanoChem"),
Flexible Solutions Ltd., Flexible Biomass LP, FS Biomass Inc., NCS Deferred Corp., Natural Chem SEZC Ltd., InnFlex Holdings Inc., ENP
Peru Investments LLC ("ENP Peru"), Pana Chem Solutions Inc., its 80 % controlling interest in 317 Mendota LLC ("317
Mendota"), and its 65 % controlling interest in ENP Investments, LLC ("ENP Investments") and ENP Mendota, LLC ("ENP
Mendota"). All inter-company balances and transactions have been eliminated upon consolidation. The Company was incorporated on
May 12, 1998 in the State of Nevada and in 2019, the Company redomiciled into Alberta, Canada.

 In
2022, NanoChem purchased an additional 50 % in ENP Peru, increasing its share to 91.67 %. ENP Investments owns the remaining 8.33 %, of
which the Company has a 65 % interest. In 2023, NanoChem purchased the remaining 8.33 % of shares to become sole owner. ENP Peru was previously
accounted for under the equity method however, it is now consolidated into the financial statements from the date control was obtained.

 In
2023, the Company purchased an 80 % interest in 317 Mendota, a newly incorporated company established to purchase a large manufacturing
building. ENP Investments will occupy part of this building, freeing up more space in the building owned by ENP Peru for NanoChem. The
Company intends to rent the remainder of the space to suitable tenants. The remaining 20 % non-controlling interest is held by unrelated
parties.

 The
Company and its subsidiaries develop, manufacture and market specialty chemicals which slow the evaporation of water. One product, HEATSAVR,
is marketed for use in swimming pools and spas where its use, by slowing the evaporation of water, allows the water to retain a higher
temperature for a longer period of time and thereby reduces the energy required to maintain the desired temperature of the water in the
pool. Another product, WATERSAVR, is marketed for water conservation in irrigation canals, aquaculture, and reservoirs where its
use slows water loss due to evaporation. In addition to the water conservation products, the Company also manufactures and markets water-soluble
chemicals utilizing thermal polyaspartate biopolymers (hereinafter referred to as "TPAs"), which are beta-proteins manufactured
from the common biological amino acid, L-aspartic. TPAs can be formulated to prevent corrosion and scaling in water piping within the
petroleum, chemical, utility and mining industries. TPAs are also used as proteins to enhance fertilizers in improving crop yields and
can be used as additives for household laundry detergents, consumer care products and pesticides. The TPA division also manufactures
two nitrogen conservation products for agriculture that slows nitrogen loss from fields and has installed custom equipment used to produce
food and nutritional materials. All the ingredients we produce are custom products for specific clients and are confidential. We anticipate
that this market vertical will grow over time.

 2.
 SIGNIFICANT ACCOUNTING POLICIES

 These
consolidated financial statements have been prepared on a historical cost basis, except where otherwise noted, in accordance with accounting
principles generally accepted in the United States applicable to a going concern and reflect the policies outlined below.

 (a)
 Cash and Cash Equivalents.

 The
Company considers all highly liquid investments purchased with an original or remaining maturity of less than three months at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with several financial institutions. As of December 31,
2024 and 2023, the Company did not have any cash equivalents.

 F- 8

 (b)
 Term Deposits.

 The
Company has four term deposits that are maintained by commercials banks. The first term deposit is for $ 303,954 and matures in February
2025. This deposit pays 3 % interest and if withdrawn before maturity, a penalty may be applied. The second term deposit is for $ 742,834,
matures in March 2025 and pays interest at a rate of 2.65 %. If withdrawn before maturity, the greater of the loss of accrued interest
or $ 150, plus 1% of the principal shall be levied. The third term deposit is for $ 1,038,721 and matures in March 2025. This deposit pays
 2.5 % and if withdrawn before maturity, the greater of the loss of accrued interest or $ 150, plus 1% of the principal shall be levied.
The fourth term deposit is for $ 315,407, matures in February 2025 and pays interest at a rate of 3 %. If withdrawn before maturity, a
penalty may be applied.

 (c)
 Inventories and Cost of Sales.

 The
Company has three major classes of inventory: completed goods, work in progress and raw materials and supplies. In all classes inventories
are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis or weighted average cost formula
to inventories in different subsidiaries. Cost of sales includes all expenditures incurred in bringing the goods to the point of sale.
Inventory costs and costs of sales include direct costs of the raw material, inbound freight charges, warehousing costs, handling costs
(receiving and purchasing) and utilities and overhead expenses related to the Company's manufacturing and processing facilities.
Shipping and handling charges billed to customers are included in revenue (2024 - $ 473,843; 2023 - $ 522,033). Shipping and handling costs
incurred are included in cost of goods sold (2024 - $ 895,463; 2023 - $ 944,811).

 (d)
 Allowance for Doubtful Accounts.

 The
Company's expected credit losses are determined through a review using historical credit loss experience; changes in asset specific
characteristics, current conditions, and reasonable and supportable future forecasts, among other specific account data, and is performed
at least quarterly. The Company develops and documents its methodology to determine its allowance for expected credit losses. Risk characteristics
used by the Company may include customer mix, knowledge of customers and general economic conditions of the various local economics,
among others. Specific account balances are written off when management determines the amounts to be uncollectible. Management has reviewed
the balance reserved through the allowance for expected losses and believes it is reasonable.

 (e)
 Property, Equipment, Leaseholds and Intangible Assets.

 The
following assets are recorded at cost and depreciated using the methods and annual rates shown below:

 SCHEDULE OF METHOD OF DEPRECIATION

 Manufacturing
 equipment

 20%
 Declining balance

 Office
 equipment

 20%
 Declining balance

 Building
 and improvements

 10%
 Declining balance

 Automobiles

 Straight-line
 over 5 years

 Technology

 Straight-line
 over 10 years

 The
Company capitalizes expenditures for improvements that significantly extend the useful life of an asset. The Company recognizes a
gain (loss) on a sale of property, equipment, leaseholds and intangible assets based upon the proceeds received on the sale less the
net carrying value of the asset. The Company charges expenditures for maintenance and repairs to operations when
incurred.

 F- 9

 (f)
 I mpairment of Long-Lived Assets.

 Property,
Equipment, Leasehold, and Definite-lived Intangible Assets:

 The
Company reviews the carrying amount of our property, equipment, leasehold, and definite-lived intangible assets for impairment when events
or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. We measure recoverability of these
assets by comparing the carrying amounts to the future undiscounted cash flows that the assets or asset group are expected to generate.
If the carrying value of the assets or asset group are not recoverable, impairment is measured and recognized as the amount by which
the carrying value exceeds its fair value. Fair value is generally determined based on discounted future cash flows.

and Indefinite-lived Intangible Assets:

and indefinite-lived intangible assets are tested for impairment annually by the Company on December 31 or more frequently if events
or changes in circumstances indicate that the carrying amount may not be recoverable. Goodwill is tested for impairment at the reporting
unit level using a two-step process which includes a qualitative and quantitative assessment. Indefinite-lived intangible assets are
tested for impairment by comparing their fair value to their carrying amount. If the carrying amount exceeds the fair value, an impairment
loss is recognized in the period it is identified. The Company determines fair value using appropriate valuation methodologies, including
discounted cash flow models and market-based approaches, which incorporate assumptions regarding future performance, growth rates, discount
rates, and other relevant factors. Any impairment losses recognized are recorded as an expense in the consolidated statements of income.

 (g)
 Foreign Currency.

 The
functional currency of the Company is the U.S. dollar. The functional currency of three of the Company's subsidiaries is the Canadian
dollar. The translation of the Canadian dollar to the reporting currency of the Company, the U.S. dollar, is performed for assets and
liabilities using exchange rates in effect at the balance sheet date. Revenue and expense transactions are translated using average exchange
rates prevailing during the period. Translation adjustments arising on conversion of the Company's financial statements from the
subsidiary's functional currency, Canadian dollars, into the reporting currency, U.S. dollars, are excluded from the determination
of income (loss) and are disclosed as other comprehensive income in the consolidated statements of operations and comprehensive income.

 Foreign
exchange gains and losses relating to transactions not denominated in the applicable local currency are included in operating income
(loss) if realized during the year and in comprehensive income (loss) if they remain unrealized at the end of the year.

 (h)
 Revenue Recognition.

 The
Company generates revenue primarily from energy and water conservation products and biodegradable polymers, as further discussed in Note
17.

 The
Company follows a five-step model for revenue recognition. The five steps are: (1) identification of the contract(s) with the customer,
(2) identification of the performance obligation(s) in the contract(s), (3) determination of the transaction price, (4) allocation of
the transaction price to the performance obligation, and (5) recognition of revenue when (or as) the performance obligation is satisfied.
The Company has fulfilled its performance obligations when control transfers to the customer, which is generally at the time the product
is shipped since risk of loss is transferred to the purchaser upon delivery to the carrier. For shipments which are free-on-board shipping
point, the Company has elected to account for shipping and handling activities as a fulfillment cost rather than as an additional promised
service and performance obligation.

 Since
the Company's inception, product returns have been insignificant; therefore, no provision has been established for estimated product
returns.

 Deferred
revenues consist of products sold to distributors with payment terms greater than the Company's customary business terms due to
lack of credit history or operating in a new market in which the Company has no prior experience. The Company defers the recognition
of revenue until the criteria for revenue recognition has been met and payments become due or cash is received from these distributors.

 F- 10

 (i)
 Stock Issued in Exchange for Services.

 The
Company's common stock issued in exchange for services is valued at fair value based upon trading prices of the Company's
common stock on the dates of the stock transactions. The corresponding expense of the services rendered is recognized over the period
that the services are performed.

 (j)
 Stock-based Compensation.

 Stock-based
compensation expense is recognized for equity awards granted to employees, directors and other eligible participants based on the fair
value of the awards at the grant date. For stock options, fair value is estimated using an appropriate valuation model such as the Black-Scholes
option pricing model. The fair value of stock options is recognized as an expense of the requisite service period, typically the vesting
period, using the graded-vesting method. The Company estimates expensed forfeitures based on historical data and adjusts stock-based
compensation expenses accordingly. Shares are issued from Treasury upon exercise of stock options.

 (k)
 Other Comprehensive Income.

 Other
comprehensive income refers to revenues, expenses, gains and losses that under generally accepted accounting principles are included
in comprehensive income, but are excluded from net income as these amounts are recorded directly as an adjustment to stockholders'
equity. The Company's other comprehensive income is comprised only of unrealized foreign exchange gains and losses related to the
translation of subsidiaries' functional currency into the reporting currency.

 (l)
 Income Per Share.

 Basic
earnings per share is computed by dividing income available to common stockholders by the weighted average number of common shares outstanding
in the period. Diluted earnings per share are calculated giving effect to the potential dilution of the exercise of options and warrants.
Common equivalent shares, composed of incremental common shares issuable upon the exercise of stock options and warrants are included
in diluted net income per share to the extent that these shares are dilutive. Common equivalent shares that have an anti-dilutive effect
on net income per share have been excluded from the calculation of diluted weighted average shares outstanding for the years ended December
31, 2024 and 2023.

 (m)
 Use of Estimates.

 The
preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates and would impact the results of operations and cash flows.

 Estimates
and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the
estimates are revised and in any future periods affected.

 Significant
areas requiring the use of management estimates include assumptions and estimates relating to the valuation of goodwill and intangible
assets, valuation of assets acquired at fair value, asset impairment analysis, share-based payments, valuation allowances for deferred
income tax assets, determination of useful lives of property, equipment and leaseholds and intangible assets, recoverability of accounts
receivable, recoverability of investments, discount rates for right of use assets and the costing and recoverable value of inventory.

 F- 11

 (n)
 Fair Value of Financial Instruments.

 Fair
value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal
or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.
Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.
The standard describes a fair value hierarchy based on three levels of inputs described below, of which the first two are considered
observable and the last unobservable, that may be used to measure fair value.

 Level
 1 – Quoted prices in active markets for identical assets or liabilities.

 Level
 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets
 or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable
 market data for substantially the full term of the assets or liabilities.

 Level
 3 — Unobservable inputs that are supported by little or no market activity which is significant to the fair value of the assets
 or liabilities.

 The
fair values of cash, term deposits, investments and the line of credit for all periods presented approximate their respective carrying
amounts due to the short term nature of these financial instruments.

 The
fair value of the long term debt for all periods presented approximate their respective carrying amounts due to these financial instruments
being at market rates.

 (o)
 Contingencies.

 Certain
conditions may exist as of the date the consolidated financial statements are issued which may result in a loss to the Company but which
will only be resolved when one or more future events occur or fail to occur. The Company's management and its legal counsel assess
such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related
to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company's
legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount
of relief sought or expected to be sought therein.

 If
the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability
can be estimated, the estimated liability would be accrued in the Company's consolidated financial statements. If the assessment
indicates that a potential material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated,
then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would
be disclosed.

 Loss
contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.
Legal fees associated with loss contingencies are expensed as incurred. The Company is not aware of any contingencies at the date of
these consolidated financial statements.

 (p)
 Income Taxes.

taxes are computed by multiplying the Company's taxable net income by the Company's effective tax rates. Deferred income
tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial
statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss carry-forwards, if any.
Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change
in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided to reduce the
carrying amount of deferred income tax assets if it is considered more likely than not that some portion, or all, of the deferred income
tax assets will not be realized.

 F- 12

 It
is the Company's policy to provide for uncertain tax positions and the related interest and penalties based upon management's
assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. At December 31, 2024,
the Company believes it has appropriately accounted for any unrecognized tax benefits.

 To
the extent the Company prevails in matters for which a liability for an unrecognized benefit is established or is required to pay amounts
in excess of the liability, the Company's effective tax rate in a given financial statement period may be affected. Interest and
penalties associated with the Company's tax positions are recorded as interest expense in the consolidated statements of income
and comprehensive income.

 (q)
 Risk Management.

 The
Company's credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated
balance sheets are net of allowances for doubtful accounts, estimated by the Company's management based on prior experience and
the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure
is minimized by dealing with only credit worthy counterparties. Revenue for the Company's three primary customers totaled $ 20,779,311
( 54 %) for the year ended December 31, 2024 (2023 - $ 20,482,798 or 53 %). Accounts receivable for the Company's three primary customers
totaled $ 7,585,199 ( 65 %) at December 31, 2024 (2023 - $ 6,561,164 or 67 %).

 The
credit risk on cash is limited because the Company limits its exposure to credit loss by placing its cash with major financial institutions.
The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced
any losses in such accounts.

 The
Company is exposed to foreign exchange risk to the extent that market value rate fluctuations materially differ for financial assets
and liabilities denominated in foreign currencies.

 In
order to manage its exposure to foreign exchange risks, the Company closely monitors the fluctuations in the foreign currency exchange
rates and the impact on the value of cash, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged
its exposure to currency fluctuations.

 The
Company is exposed to interest rate risk to the extent that the fair value or future cash flows for financial liabilities will fluctuate
as a result of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt subject to fixed
long-term interest rates.

 In
order to manage its exposure to interest rate risk, the Company closely monitors fluctuations in market interest risks and will refinance
its long-term debt where possible to obtain more favourable rates.

 (r)
 Leases.

 Leases
are evaluated and classified as either operating or finance leases by the lessee and as either operating, sales-type or direct financing
leases by the lessor. For leases with terms greater than 12 months, the Company records the related right-of-use ("ROU")
asset and lease obligation at the present value of lease payments over the term. Leases may include fixed rental escalation clauses,
renewal options and / or termination options that are factored into the determination of lease payments when appropriate. The Company's
operating leases are included in ROU assets, lease liabilities-current portion and lease liability-long term portion in the accompanying
consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term, and lease
liabilities represent the obligation to make lease payments arising from the lease. The Company's leases do not usually provide
a readily determinable implicit rate; therefore, an estimate of the Company's incremental borrowing rate is used to discount the
lease payments based on information available at the lease commencement date.

 F- 13

 (s)
 Investments.

 Investment,
at cost

 The
Company accounts for investments in equity securities that do not have a readily determinable fair value using the cost method. These
investments are initially recorded at cost and are not subsequently remeasured unless impaired. Dividends received from cost-method investments
are recognized as income when declared, provided they do not represent a return of capital. The Company evaluates these investments for
impairment at each reporting period based on qualitative factors, such as financial condition, operational performance, and general market
conditions affecting the investee. If an investment is determined to be impaired and the impairment is considered other than temporary,
the carrying amount is reduced to its estimated recoverable value, with the impairment loss recognized in earnings.

 Investment,
equity method

 The
Company accounts for investments in entities over which it has significant influence, but not control, using the equity method of accounting.
Under the equity method, the investment is initially recorded at cost, and the carrying amount is subsequently adjusted for the Company's
share of the investee's income, losses, and dividends received. When a portion of an equity-method investment is sold, the Company
recognizes a gain or loss on the sale based on the difference between the carrying amount of the investment sold and the proceeds received.
The Company adjusts the carrying amount of the remaining investment based on its proportionate share of the investee's equity after
the sale. The Company assesses its equity-method investments for impairment whenever events or changes in circumstances indicate that
the carrying amount may not be recoverable. If the carrying amount of an equity-method investment exceeds its recoverable amount, an
impairment loss is recognized.

 (t)
 Reclassification.

 Certain
prior year amounts have been reclassified to conform to the 2024 financial statements presentation. Reclassifications had no effect on
net income, cash flows, or stockholders' equity as previously reported.

 (u)
 Goodwill and Intangible Assets.

represents the excess of the purchase price over the fair value of identifiable net assets acquired in a business combination. Goodwill
is assigned to reporting units at the date of acquisition and is not amortized but is subject to periodic impairment testing. The carrying
amount of goodwill is adjusted only in the event of impairment or upon the disposal of a business.

 Intangible
Assets

 Intangible
assets acquired separately are recorded at cost, while those acquired in a business combination are recognized at fair value as of the
acquisition date. Intangible assets are classified into the following categories:

 Definite-Lived
 Intangible Assets – These assets are amortized over their estimated useful lives on
 a straight-line basis or another systematic basis that better reflects the pattern of consumption
 of economic benefits. The estimated useful lives of these assets are reviewed periodically
 to determine whether adjustments are necessary.

 Indefinite-Lived
 Intangible Assets – Certain intangible assets are classified as indefinite-lived when
 there is no foreseeable limit to the period over which they are expected to contribute to
 cash flows. These assets are not amortized but are subject to periodic evaluation to confirm
 their classification remains appropriate.

 (v)
 Recent Accounting Pronouncements.

 In
November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07
( Topic 280) Improvements to Reportable Segment Disclosures. The new guidance requires disclosure of significant segment expenses
that are (1) regularly provided to or easily computed from information regularly provided to the chief operating decision maker and (2)
included in the reported measure of segment profit or loss. The new standard also allows companies to disclose multiple measures of segment
profit or loss if those measures are used to assess performance and allocate resources. We adopted this guidance which resulted in additional
required disclosures included in our consolidated financial statements for the year ended December 31, 2024 and segment disclosure for
the comparative year ended December 31, 2023 were modified retrospectively to include the new requirements.

 F- 14

 In
December 2023, the FASB issued ASU 2023-09 ( Topic 740) Improvements to Income Tax Disclosures. The new guidance is intended to
enhance annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present
in an entity's operations. The amendments in this standard require disclosure of additional information in specified categories
with respect to the reconciliation of the effective tax rate to the statutory rate (the rate reconciliation) for federal, state, and
foreign income taxes. They also require greater detail about individual reconciling items in the rate reconciliation to the extent the
impact of those items exceeds a specified threshold. In addition to new disclosures associated with the rate reconciliation, the amendments
in this update require information pertaining to taxes paid (net of refunds received) to be disaggregated for federal, state, and foreign
taxes and further disaggregated for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. The amendments
in this update are effective on January 1, 2025 for annual periods beginning after December 15, 2024, and early adoption is permitted.
The Company does not expect the adoption to have a material impact on the consolidated financial statements and has not early adopted
the standard.

 In
November 2024, the FASB issued ASU 2024-03, I ncome Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures
(Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure about the types of costs and expenses included
in certain expense captions presented on the income statement. The new disclosure requirements are effective for the Company's
annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted,
and may be applied either prospectively or retrospectively. The Company is currently evaluating the ASU to determine its impact on our
consolidated financial statements and disclosures.

 Management
does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material
effect on the accompanying financial statements.

 3.
 LEASES

 In
January 2016, NanoChem Solutions Inc. leased a space in Naperville, IL for office and research and development. The lease was for an
initial five years and renewable every five years for a further five years. In March 2024, the Company consolidated NanoChem operations
into the Peru, IL locations and terminated the lease in Naperville, IL. The Company had to pay a penalty of $ 35,910 and forfeited the
$ 5,440 security deposit to terminate the lease early and incurred a loss of $ 41,350 on early termination of the lease that is shown on
the consolidated statement of income and comprehensive income as a part of non-operating income (loss). The table below summarizes the
right-of-use asset and lease liability for the periods ended December 31, 2024 and 2023.

 SUMMARY OF RIGHT-OF-USE ASSET AND LEASE LIABILITY

 Right of Use Assets

 Balance at December 31, 2022

 $
 167,222

 Amortization

 ( 51,929
)

 Balance at December 31, 2023

 $
 115,293

 Amortization

 ( 13,694
)

 Early termination of lease

 ( 101,599
)

 Balance at December 31, 2024

 $
 -

 Lease Liability

 Balance at December 31, 2022

 $
 167,222

 Lease interest expense

 6,151

 Payments

 ( 58,080
)

 Balance at December 31, 2023

 $
 115,293

 Lease interest expense

 1,186

 Payments

 ( 14,880
)

 Early termination of lease

 ( 101,599
)

 Balance at December 31, 2024

 $
 -

 F- 15

 4.
 ACCOUNTS RECEIVABLE

 SCHEDULE OF ACCOUNTS RECEIVABLE

 2024

 2023

 Accounts receivable

 $
 11,983,200

 $
 10,133,249

 Allowances for doubtful accounts

 ( 287,102
)

 ( 290,193
)

 Total
 accounts receivable

 $
 11,696,098

 $
 9,843,056

 5.
 INVENTORIES

 SCHEDULE OF INVENTORY

 2024

 2023

 Completed goods

 $
 3,060,508

 $
 2,682,158

 Raw materials and supplies

 7,829,687

 8,452,731

 Total
 inventory

 $
 10,890,195

 $
 11,134,889

 6.
 PROPERTY, EQUIPMENT AND LEASEHOLDS

 SCHEDULE OF PROPERTY, EQUIPMENT AND LEASEHOLDS

 2024

 Accumulated

 2024

 Cost

 Depreciation

 Net

 Buildings and improvements

 $
 12,795,750

 $
 4,521,212

 $
 8,274,538

 Automobiles

 196,255

 168,807

 27,448

 Office equipment

 124,526

 117,011

 7,515

 Manufacturing equipment

 15,318,758

 6,922,667

 8,396,091

 Land

 440,592

 —

 440,592

 Leasehold improvements

 10,000

 10,000

 —

 Technology

 94,945

 94,945

 —

 $
 28,980,826

 $
 11,834,642

 $
 17,146,184

 2023

 Accumulated

 2023

 Cost

 Depreciation

 Net

 Buildings and improvements

 $
 12,341,605

 $
 3,896,887

 $
 8,444,718

 Automobiles

 196,255

 140,040

 56,215

 Office equipment

 177,623

 165,048

 12,575

 Manufacturing equipment

 10,017,466

 5,799,779

 4,217,687

 Land

 440,592

 —

 440,592

 Leasehold improvements

 88,872

 88,872

 —

 Technology

 103,292

 103,292

 —

 $
 23,365,705

 $
 10,193,918

 $
 13,171,787

 Amount
of depreciation expense for 2024 was: $ 1,797,476 (2023 - $ 1,526,319) and is included in cost of sales in the consolidated statements
of income and comprehensive income.

 In
2023, the Company sold the boat and $ 4,589 was recognized as a gain on sales of asset in the consolidated statements of income and comprehensive
income.

 F- 16

 7.
 GOODWILL AND INTANGIBLE ASSETS

and intangibles assets, all of which relates to the acquisition of ENP Investments in 2018, at December 31, 2024 and 2023 consisted of
the following:

 SCHEDULE OF GOODWILL AND INDEFINITE LIVED INTANGIBLE ASSETS

 December 31, 2024

 December 31, 2023

 $
 2,534,275

 $
 2,534,275

 Intangibles Assets:

 Indefinite lived – trade secrets and trademarks

 770,000

 770,000

 Definite lived – customer lists

 2,350,000

 2,350,000

 Accumulated amortization on definite-lived intangibles assets

 ( 1,000,000
)

 ( 840,000
)

 Net definite-lived intangible assets

 1,350,000

 1,510,000

 Total intangible assets

 $
 2,120,000

 $
 2,280,000

 The
amount of amortization for 2024 was $ 160,000 (2023 - $ 160,000) and was included in cost of sales in the consolidated statements of income
and comprehensive income. Estimated amortization expense over the next five years is as follows:

 SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE

 2025

 $

 2026

 2027

 2028

 2029

 8.
 LONG TERM DEPOSITS

 The
Company has security deposits that are long term in nature which consist of damage deposits held by lessors and deposits held by various
vendors for equipment purchases.

 SCHEDULE OF LONG TERM DEPOSITS

 2024

 2023

 Long term deposits

 $
 167,882

 $
 824,254

 9.
 INVESTMENTS

 The Company's investments at December
31, 2024 and 2023 consisted of the following:

OF COMPANY'S INVESTMENTS

 2024

 2023

 Investments, at cost:

 Lygos Inc., simple agreement for future equity ("SAFE")
 agreement

 $
 1,000,000

 $
 1,000,000

 Trio Opportunity Corp., 97,000 non-voting Class B shares

 970,000

 970,000

 Investments, at cost:

 970,000

 970,000

 Investment, equity method:

 Florida-based LLC

 1,454,381

 4,063,960

 Total

 $
 3,424,381

 $
 6,033,960

 In
January 2019, the Company invested in a Florida based LLC that is engaged in international sales of fertilizer additives. According to
the operating agreement, the Company had a 50 % interest in the profit and loss of the Florida based LLC but does not have control. In
August 2024, the Company sold a
 30.1 % interest in the Florida based LLC to a third party for consideration of $ 2,000,000. In addition,
the Company entered a subsequent agreement for the sale of its remaining 19.9 % interest over the next five years for an additional $ 4,000,000.
Starting in 2025, the Company will sell a further 3.98 % per year upon receipt of that years $ 800,000 payment. At December 31, 2024, the
Company continues to account for this investment using the equity investment as it exercises significant influence.

 F- 17

 A
summary of the activity associated with the Company's investment in the Florida based LLC during the years ended December 31, 2024
and 2023 is follows:

 SCHEDULE OF EQUITY METHOD INVESTMENT

 Balance, December 31, 2022 – 50% interest

 $
 3,758,895

 Balance, December 31, 2022 – 50 % interest

 $
 3,758,895

 Company's proportionate share of earnings

 505,065

 Distribution received

 ( 200,000
)

 Sale of 30.1% of Florida based LLC

 Balance, December 31, 2023 – 50 % interest

 4,063,960

 Company's proportionate share of earnings

 244,857

 Distribution received

 ( 510,710
)

 Basis of 30.1 % of interest sold

 ( 2,343,726
)

 Balance, December 31, 2024 – 19.9 % interest

 $
 1,454,381

 Summarized profit and loss information related to the Florida based LLC is as follows:

 SUMMARY OF PROFIT AND LOSS INFORMATION RELATED TO EQUITY ACCOUNTED INVESTMENT

 2024

 2023

 Net sales

 $
 13,046,436

 $
 16,043,468

 Gross profit

 3,640,973

 4,668,177

 Net income

 $
 455,241

 $
 1,010,128

the year ended December 31, 2024, the Company had sales of $ 8,235,394 (2023 - $ 10,260,870) to the Florida based LLC, of which $ 1,866,645
is included within Accounts Receivable as at December 31, 2024 (2023 - $ 2,073,813).

 10.
 LINE OF CREDIT

 ( a)
 In June 2024, ENP Investments renewed the
line of credit with Stock Yards Bank and Trust ("Stock Yards"). The revolving line of credit is for an aggregate amount of
up to the lesser of (i) $ 4,500,000, or (ii) 50 - 80 % of eligible domestic accounts receivable plus 50 % of inventory, capped at $ 2,000,000.
Interest on the unpaid principal balance of this loan will be calculated using the greater of prime or 4.0 %. The interest rate at December
31, 2024 is 7.5 % (2023 - 8.5 %).

 The
revolving line of credit contains customary affirmative and negative covenants, including the following: compliance with laws, provisions
of financial statements and periodic reports, payment of taxes, maintenance of inventory and insurance, maintenance of operating accounts
at Stock Yards, Stock Yard's access to collateral, formation or acquisition of subsidiaries, incurrence of indebtedness, dispositions
of assets, granting liens, changes in business, ownership or business locations, engaging in mergers and acquisitions, making investments
or distributions and affiliate transactions. NanoChem is a guarantor of 65 % of all the principal and other loan costs not to exceed $ 2,925,000.
The non-controlling interest is the guarantor of the remaining 35 % of all the principal and other loan costs not to exceed $ 1,575,000.

 To
secure the repayment of any amounts borrowed under the revolving line of credit, the Company granted Stock Yards a security interest
in substantially all of the assets of ENP Investments, exclusive of intellectual property assets.

 The
balance outstanding under this revolving line as of December 31, 2024 was $ 2,052,159 (2023 - $ 1,810,479).

 F- 18

 (b)
 In August 2024, the Company renewed the line of credit with Stock Yards Bank and Trust ("Stock Yards"). The revolving
line of credit is for an aggregate amount of up to the lesser of (i) $ 2,000,000, or (ii) 80 % of eligible domestic accounts receivable
and certain foreign accounts receivable plus 50 % of inventory, capped at $ 1,000,000. Interest on the unpaid principal balance of this
loan will be calculated using the greater of prime or 4.0 %. The interest rate at December 31, 2024 is 8 % (2023 - 8.5 %).

 The
revolving line of credit contains customary affirmative and negative covenants, including the following: compliance with laws, provision
of financial statements and periodic reports, payment of taxes, maintenance of inventory and insurance, maintenance of operating accounts
at Stock Yards, Stock Yards access to collateral, formation or acquisition of subsidiaries, incurrence of indebtedness, dispositions
of assets, granting liens, changes in business, ownership or business locations, engaging in mergers and acquisitions, making investments
or distributions and affiliate transactions. The covenants also require that the Company maintain a minimum ratio of qualifying financial
assets to the sum of qualifying financial obligations.

 To
secure repayment of any amounts borrowed under the revolving line of credit, the Company granted Stock Yards a security interest in substantially
all of the assets of NanoChem, exclusive of intellectual property assets.

 The
balance outstanding under this revolving line as of December 31, 2024 were $ nil (2023 - $ nil).

 11.
 LONG TERM DEBT

 Debt,
all of which is with StockYards Bank and Trust, at December 31, 2024 and 2023 consisted of the following:

OF LONG TERM DEBT

 December 31, 2024

 December 31, 2023

 ENP Mendota, 10 -year mortgage, 4.35 % to 5 year fixed index plus 4.50 % interest, monthly
 payments through to January 2030, collateralized by real property and all rents on said property

 $
 387,577

 $
 399,269

 NanoChem, 3 -year note payable, 4.90 % interest, monthly principal and interest payments through June
 2025, collateralized by real property

 345,036

 1,004,748

 ENP Peru, 10 -year mortgage,
 4.35 % interest, monthly principal and interest payments through January 2030, collateralized by real property (1 st mortgage)

 2,658,381

 2,737,232

 ENP Peru, 10 -year mortgage, 5.4 % interest, monthly principal payments plus interest through June 2032,
 collateralized by real property (2nd mortgage)

 243,957

 250,207

 NanoChem, 3 -year note payable, 6.5 % interest, interest only payments through to July 2024, then monthly
 principal and interest payments through December 2025, collateralized by manufacturing equipment

 1,355,285

 1,475,188

 317 Mendota, 5 -year note payable, 6.79 % interest, interest only payments through June 2024, then monthly
 principal and interest payments through June 2028 with lump sum payment of $ 2,024,710 due in June 2028, collateralized by real property

 2,223,667

 2,248,292

 Nanochem, 5 -year note payable, 7.0 % interest, monthly principal payments plus interest
 through August 2029, collateralized by manufacturing equipment

 1,545,945

 -

 Long-term debt

 8,759,848

 8,114,936

 Less: current portion

 ( 2,140,981
)

 ( 1,281,632
)

 Long-term debt non current

 $
 6,618,867

 $
 6,833,304

 F- 19

 The
following table summarizes the scheduled annual future principal payments as of December 31, 2024

OF ANNUAL FUTURE PRINCIPAL PAYMENTS

 Year Ended December 31,

 Principal Amount Due

 2025

 $
 2,140,981

 2026

 467,149

 2027

 498,454

 2028

 2,530,128

 Thereafter

 3,123,136

 Total

 $
 8,759,848

 12.
 INCOME TAXES

 The
provision for income tax expense (benefit) is comprised of the following:

 SCHEDULE OF PROVISION FOR INCOME TAX EXPENSE (BENEFIT)

 2024

 2023

 Current tax, federal

 $
 763,471

 $
 753,683

 Current tax, state

 345,380

 340,952

 Current tax, foreign

 217,552

 151,236

 Current tax expense

 1,326,403

 1,245,871

 Income tax benefit

 ( 621,959
)

 ( 1,127,689
)

 Current tax, total expense

 704,444

 118,182

 Deferred income tax, federal

 101,053

 ( 172,763
)

 Deferred income tax, state

 45,714

 ( 78,154
)

 Deferred income tax, foreign

 -

 -

 Deferred income tax, total expense (benefit)

 146,767

 ( 250,917
)

 Total

 $
 851,211

 $
 ( 132,735
)

 The
following table reconciles the income tax expense at the U.S. Federal statutory rate to income tax expense at the Company's effective
tax rates.

 SCHEDULE OF RECONCILIATION OF INCOME TAXES

 2024

 2023

 before income tax - United States

 $
 4,472,950

 $
 3,249,901

 before income tax - Canada

 479,850

 373,349

 before income tax

 4,952,800

 3,623,250

 US
 federal statutory tax rate

 21.00
 %

 21.00
 %

 Expected
 income tax expense

 1,040,088

 760,883

 State
 income tax expense, net of federal tax benefit

 371,708

 344,208

 Non-deductible
 items

 64,857

 362,554

 Change in
 estimates and other

 ( 194,142
)

 ( 1,585,427
)

 Foreign tax
 rate differential

 ( 35,952
)

 ( 92,379
)

 Change
 in valuation allowance

 ( 395,348
)

 77,426

 Total
 income taxes expense (benefit)

 $
 851,211

 $
 ( 132,735
)

 Included
in current income tax expense for the year ended December 31, 2024 is a recovery of $ 621,959 (2023 - $ 1,127,689) for a revision of estimated
current taxes payable for previous years.

 Deferred
taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting
purposes. Deferred tax assets (liabilities) at December 31, 2024 and 2023 are comprised of the following:

 SCHEDULE OF DEFERRED TAX ASSETS (LIABILITIES)

 2024

 2023

 Canada

 Non-capital loss carryforwards

 $
 1,059,468

 $
 855,176

 Share issuance costs

 1,024

 -

 Property, equipment and leaseholds

 27,995

 30,916

 Deferred tax assets gross

 1,088,487

 886,092

 Valuation allowance

 ( 1,088,487
)

 ( 886,092
)

 Net deferred tax asset

 $
 -

 $
 -

 F- 20

 2024

 2023

 United States

 Net
 operating loss carryforwards

 $
 190,024

 $
 -

 Property,
 equipment and leaseholds

 502,646

 36,093

 Deferred
 tax asset

 692,670

 36,093

 Valuation
 allowance

 ( 192,953
)

 -

 Net deferred tax asset

 $
 499,717

 $
 36,093

 Intangible
 assets

 $
 ( 516,414
)

 $
 ( 11,346
)

 Investments

 ( 105,322
)

 -

 Deferred
 tax liability

 ( 621,736
)

 ( 11,346
)

 Net
 deferred tax asset (liability)

 $
 ( 122,019
)

 $
 24,747

 The
Company has non-capital loss carryforwards of approximately $ 4,606,383 which may be carried forward to apply against
future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the
following years:

 SCHEDULE OF NON OPERATING LOSS CARRYFORWARDS

 Loss

 2030

 $
 249,807

 2031

 865,746

 2032

 566,109

 2037

 1,555,780

 2039

 134,471

 2040

 396,186

 2041

 301,063

 2042

 315,157

 2043

 222,064

 Total

 $
 4,606,383

 As
at December 31, 2024, the Company has federal and state income tax net operating loss carryforwards of $ 623,028 available for US tax
purposes. The NOLs carry forward indefinitely, with utilization limited to offsetting up to 80% of taxable income in any given year.

 Accounting
for Uncertainty for Income Tax

 The
Company recognizes income tax liabilities from uncertain tax positions where there is uncertainty as to a tax position being sustainable
using the more-likely-than-not threshold. During the years ended December 31, 2024 and 2023, the total liability for uncertain tax positions
increased by $ 419,214 and $ 464,185 respectively, primarily due to increased liabilities based on existing tax positions. As of December
31, 2024 and 2023, the Company has recognized liabilities for uncertain tax positions of $ 2,754,007 and $ 2,334,793, respectively, which
is included in income taxes payable on the consolidated balance sheets. All recorded uncertain tax positions impact the Company's
effective tax rate. The timing of any future settlements or payments related to uncertain tax positions is
uncertain.

 Additionally,
the Company has accrued interest and penalties related to these unrecognized tax benefits and other items, which are recorded as a component
of income tax expense (benefit). As of December 31, 2024 and 2023, the Company recorded an additional $ 333,086 and $ 193,551 in accrued
interest and penalties. At December 31, 2024 and 2023, the Company had accrued interest and penalties related to unrecognized tax benefits
of $ 1,237,637 and $ 904,549 respectively, which is included in income taxes payable on the consolidated balance sheets.

 13.
 INCOME PER SHARE

 The
Company presents both basic and diluted income per share on the face of its consolidated statements of income and comprehensive income.
Basic and diluted income per share are calculated as follows:

 SCHEDULE OF BASIC AND DILUTED LOSS PER SHARE

 2024

 2023

 Net income attributable to controlling interest

 $
 3,038,529

 $
 2,775,864

 Weighted average common shares outstanding:

 Basic

 12,454,957

 12,434,886

 Diluted

 12,680,668

 12,489,467

 Net income per common share attributable to controlling interest:

 Basic and diluted

 $
 0.24

 $
 0.22

 F- 21

 Certain
stock options whose terms and conditions are described in Note 14, "Stock Options" could potentially dilute basic EPS in
the future, but were not included in the computation of diluted EPS because to do so would have been anti-dilutive. Those anti-dilutive
options are as follows.

 SCHEDULE OF ANTI-DILUTIVE OPTIONS

 2024

 2023

 Anti-dilutive options

 745,000

 740,000

 There
were no preferred shares issued and outstanding during the years ended December 31, 2024 and 2023.

 14.
 STOCK OPTIONS

 The
Company has a stock option plan ("Plan"). The purpose of this Plan is to provide additional incentives to key employees,
officers, directors and consultants of the Company and its subsidiaries in order to help attract and retain the best available personnel
for positions of responsibility and otherwise promote the success of the Company's business. It is intended that options issued
under this Plan constitute non-qualified stock options. The general terms of awards under the option plan are that 100 % of the options
granted will vest the year following the grant unless a executive employee is granted a multi-year stock option grant where an equal
amount vests over the next 5 years. The maximum term of options granted is 5 years and the exercise price for all options are issued
for not less than fair market value at the date of the grant.

 The
following table summarizes the Company's stock option activities for the years ended December 31, 2024 and 2023:

 SCHEDULE OF STOCK OPTION ACTIVITIES

 Number of shares

 Exercise price
 per share

 Weighted average
 exercise price

 Balance, December 31, 2022

 1,686,000

 $
 1.70
 – 4.13

 $
 3.26

 Cancelled or expired

 ( 564,000
)

 $
 3.46
 – 4.13

 $
 3.55

 Exercised

 ( 8,000
)

 $
 1.70

 $
 1.70

 Balance, December 31, 2023

 1,114,000

 $
 1.75
 – 3.61

 $
 3.13

 Granted

 1,081,000

 $
 2.00
 – 4.05

 $
 2.12

 Cancelled or expired

 ( 275,000
)

 $
 1.75
 – 3.61

 $
 2.54

 Exercised

 ( 80,000
)

 $
 1.75
 – 2.44

 $
 2.31

 Balance, December 31, 2024

 1,840,000

 $
 2.00
 – 4.05

 $
 2.68

 Exercisable, December 31, 2024

 939,000

 $
 2.00
 – 3.61

 $
 2.71

the years ended December 31, 2024 and 2023, the Company recognized stock based compensation associated with stock options as
follows:

OF RECOGNIZED STOCK BASED COMPENSATION

 2024

 2023

 Line item on the statement of income and comprehensive income:

 Wages and administrative salaries

 $
 623,000

 $
 331,609

 Consulting

 50,130

 63,471

 Stock
 based compensation

 $

 $

the year ended December 31, 2024, the Company granted 102,000 (2023 – nil) stock options to consultants and 979,000 (2023 –
 nil) stock options to employees. The fair value of options granted during 2024 was calculated using the following range of assumptions:

OF STOCK OPTION FAIR VALUE ASSUMPTIONS

 2024

 Expected life – years

 3.0

 Interest rate

 1.76
 – 4.11 %

 Volatility

 66.01
 – 71.59 %

 Fair value of options granted

 $ 1.46
 – 2.02

 F- 22

 As
of December 31, 2024, the weighted-average remaining contractual life of outstanding and exercisable options is 3.4 years and 3.1 years,
respectively. As of December 31, 2024, there was approximately $ 603,850 of compensation expense related to non-vested awards that is
expected to be recognized over a weighted average period of 1.9 years.

 The
aggregate intrinsic value of options outstanding and exercisable at December 31, 2024 is $ 1,709,850 (2023 - $ nil) and $ 843,790 (2023
- $ nil), respectively. During the year ended December 31, 2024, the intrinsic value of stock options exercised was $ 88,730 (2023 - $ 11,520).

 15.
 CAPITAL STOCK

the year ended December 31, 2024, 47,000 shares were issued upon the exercise of employee stock options (2023 – 8,000) and 33,000
shares were issued upon the exercise of consultant stock options (2023 – nil).

the year ended December 31, 2024, the Company announced a special dividend of $ 0.10 per share that was paid on May 16, 2024 to shareholders
for a total of $ 1,255,053 (2023 - $ 0.05 /share for a total of $ 626,777).

the year ended December 31, 2023, the Company issued 1,272 shares to a consultant for services rendered, resulting in an expense of $ 4,070
on the consolidated statements of income and comprehensive income.

 16.
 NON-CONTROLLING INTERESTS

 ( a)
 ENP Investments is a limited liability corporation
("LLC") that manufactures and distributes golf, turf and ornamental agriculture products in Mendota, Illinois. The Company
owns a 65 % interest in ENP Investments through its wholly-owned subsidiary NanoChem. An unrelated party ("NCI") owns the
remaining 35 % interest in ENP Investments. ENP Mendota is a wholly owned subsidiary of ENP Investments. ENP Mendota is a LLC that leases
warehouse space. For financial reporting purposes, the assets, liabilities and earnings of both of the LLC's are consolidated into
these financial statements. The NCI's ownership interest in ENP Investments is recorded in non-controlling interests in these consolidated
financial statements. The non-controlling interest represents NCI's interest in the earnings and equity of ENP Investments. ENP
Investments is allocated to the TPA segment. See Note 17.

 ENP
Investments makes cash distributions to its equity owners based on formulas defined within its Ownership Interest Purchase Agreement
dated October 1, 2018. Distributions are defined in the Ownership Interest Purchase Agreement as cash on hand to the extent it exceeds
current and anticipated long-term and short-term needs, including, without limitation, needs for operating expenses, debt service, acquisitions,
reserves, and mandatory distributions, if any.

 From
the effective date of acquisition onward, the minimum distributions requirements under the Ownership Interest Purchase Agreement were
satisfied. The total distribution from the effective date of acquisition onward was $ 4,020,679.

OF DISTRIBUTIONS

 Balance, December 31, 2022

 $
 2,605,034

 Distribution

 ( 719,439
)

 Non-controlling interest share of income

 1,015,604

 Balance, December 31, 2023

 2,901,199

 Distribution

 ( 794,722
)

 Non-controlling interest share of income

 1,164,037

 Balance, December 31, 2024

 $
 3,270,514

the year ended December 31, 2024, the Company had sales of $ 8,050,462 (2023 - $ 6,811,083) to the NCI, of which $ 5,377,088 is included
within Accounts Receivable as of December 31, 2024 (2023 – $ 4,225,028).

 F- 23

 b)
 317 Mendota is a LLC that owns real estate that the Company occupies part of while renting out the excess. The Company owns
a 80 % interest in 317 Mendota and an unrelated party ("317 NCI") owns the remaining 20 % interest in 317 Mendota. For financial
reporting purposes, the assets, liabilities and earnings of 317 Mendota are consolidated into these financial statements. The 317 NCI's
ownership interest in 317 Mendota is recorded in non-controlling interests in these consolidated financial statements. The non-controlling
interest represents 317 NCI's interest in the earnings and equity of 317 Mendota. 317 Mendota is allocated to the TPA segment as
that is the intended use of the building.

OF NON CONTROLLING INTEREST RELATED TO ACQUISITION

 Balance, December 31, 2022

 $
 -

 Acquisition

 Non-controlling interest share of loss

 ( 35,483
)

 Balance, December 31, 2023

 164,517

 Non-controlling interest share of loss

 ( 100,977
)

 Balance, December 31, 2024

 $
 63,540

 17.
 SEGMENT S AND SIGNIFICANT CONCENTRATIONS

 The
Company operates in two segments:

 (a)
 Energy and water conservation products (as shown under the column heading "EWCP" below), which consists of a (i) liquid
swimming pool blankets which save energy and water by inhibiting evaporation from the pool surface, and (ii) food-safe powdered form
of the active ingredient within the liquid blankets and which are designed to be used in still or slow moving drinking water sources.

 (b)
 Biodegradable polymers, also known as TPA's (as shown under the column heading "BCPA" below), used by the petroleum,
chemical, utility and mining industries to prevent corrosion and scaling in water piping. This product can also be used in detergents
to increase biodegradability and in agriculture to increase crop yields by enhancing fertilizer uptake.

 The
third product line is nitrogen conservation products used for the agriculture industry. These products decrease the loss of nitrogen
fertilizer after initial application and allows less fertilizer to be used. These products are made and sold by the Company's TPA
division.

 The
Company also manufactures food grade products that are made and sold by the TPA division.

 The
Company's reportable segments are strategic business units that offer different, but synergistic products and services. They are
managed separately because each business requires different technology and marketing strategies. The economic factors that impact the
nature, amount, timing, and uncertainty of revenue and cash flows vary among the Company's operating segments and the geographical
regions in which they operate. This operating segment structure is used by the Chief Operating Decision Maker ("CODM"), who
has been determined to be the Chief Executive Officer, to make key operating decisions and assess performance of the Company. The CODM
evaluates segment operating performance, and makes resource allocation and performance evaluation decisions, based on gross profit and
net operating income.

 Year
ended December 31, 2024:

OF REPORTABLE SEGMENTS

 EWCP

 BPCA

 Other
 (1)

 Sales

 $
 759,549

 $
 37,475,311

 $
 -

 $
 38,234,860

 Cost of sales

 350,345

 24,644,616

 -

 24,994,961

 Gross profit

 409,204

 12,830,695

 -

 13,239,899

 Wages and administrative salaries

 90,043

 3,653,182

 -

 3,743,225

 Office & Miscellaneous

 45,327

 759,410

 805,307

 Other segment items (2)

 57,056

 2,699,196

 419,709

 3,175,961

 Net operating income

 216,778

 5,718,907

 ( 420,279
)

 5,515,406

 Interest expense

 609,956

 -

 610,265

 Depreciation and amortization (included in COGS)

 15,298

 1,942,178

 -

 1,957,476

 Capital expenditures

 -

 4,964,736

 -

 4,964,736

 Assets (3)

 2,588,731

 56,415,104

 964,744

 59,968,579

 Year
ended December 31, 2023:

 EWCP

 BPCA

 Other
 (1)

 Sales

 $
 572,845

 $
 37,751,961

 $
 -

 $
 38,324,806

 Cost of sales

 359,429

 27,522,292

 -

 27,881,721

 Gross profit

 213,416

 10,229,669

 -

 10,443,085

 Wages and
 administrative salaries

 92,302

 3,772,359

 -

 3,864,661

 Office &
 Miscellaneous

 46,968

 465,535

 512,896

 Other segment
 items (2)

 79,809

 2,109,582

 376,581

 2,565,972

 Net operating
 income

 ( 5,663
)

 3,885,680

 ( 376,975
)

 3,503,042

 Interest
 expense

 498,279

 -

 498,666

 Depreciation
 (included in COGS)

 17,411

 1,668,908

 -

 1,686,319

 Capital expenditures

 -

 4,990,675

 -

 4,990,675

 Assets (3)

 3,889,596

 50,627,932

 953,527

 55,471,055

 (1)
 Other is not considered
an operating segment and includes expenses and income not identifiable to an operating segment and is not included in operating segment
results

 (2)
 Other segment items
for each reportable segment includes insurance, consulting, research, and professional fees.

 (3)
 Segment
 assets include cash, term deposits, accounts receivable, inventory, prepaid expenses, property, equipment and leaseholds, right of
 use assets, security deposits, intangible assets, and goodwill.

 F- 24

 Sales
by territory are shown below:

OF REVENUE GENERATED IN UNITED STATES AND CANADA

 2024

 2023

 Canada

 $
 400,693

 $
 755,844

 United States and abroad

 37,834,167

 37,568,962

 Total

 $
 38,234,860

 $
 38,324,806

 The
Company's long-lived assets (property, equipment, leaseholds, right of use assets, intangibles, and goodwill) are located in Canada
and the United States as follows:

OF LONG-LIVED ASSETS ARE LOCATED IN CANADA AND UNITED STATE

 2024

 2023

 Canada

 $
 116,496

 $
 142,577

 United States

 21,683,963

 17,958,778

 Total

 $
 21,800,459

 $
 18,101,355

 Three
customers accounted for $ 20,779,311 ( 54 %) of sales made in 2024 (2023 - $ 20,482,798 or 53 %).

 18.
 SUBSEQUENT EVENTS

 In
the three months ended March 31, 2025, the Company issued 67,000
shares to employees and 65,000
shares to consultants upon the exercise of stock options.

 F- 25

 Item
 9.

 in and Disagreements with Accountants on Accounting and Financial Disclosure.

 None.

 Item
 9A.

 Controls
 and Procedures.

 We
maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports
to the SEC is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and regulations,
and that such information is accumulated and communicated to our management, including our principal executive officer and principal
financial officer, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls and procedures are
designed to provide a reasonable level of assurance of reaching our desired disclosure control objectives.

 As
of the end of the period covered by this Annual Report on Form 10-K for the year ended December 31, 2024 we carried out an evaluation,
under the supervision and with the participation of management, including our principal executive officer and principal financial officer,
of the effectiveness of the design and operation of our disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e)
under the Securities Exchange Act of 1934, as amended). Based upon that evaluation, our principal executive officer and principal financial
officer concluded that our disclosure controls and procedures are effective.

 Management's
Report on Internal Control Over Financial Reporting

 Our
management is responsible for establishing and maintaining adequate internal control over financial reporting and for the assessment
of the effectiveness of internal control over financial reporting. As defined by the Securities and Exchange Commission, internal control
over financial reporting is a process designed by, or under the supervision of our principal executive officer and principal financial
officer and implemented by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of our financial statements in accordance with U.S. generally accepted accounting principles.

 Our
internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that,
in reasonable detail, accurately and fairly reflect our transactions and dispositions of our assets; (2) provide reasonable assurance
that transactions are recorded as necessary to permit preparation of our financial statements in accordance with U.S. generally accepted
accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management
and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition
of our assets that could have a material effect on the financial statements.

 Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may deteriorate.

 In
connection with the preparation of our annual financial statements, management has undertaken an assessment of the effectiveness of our
internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission, or the 2013 COSO Framework. Management's assessment
included an evaluation of the design of our internal control over financial reporting and testing of the operational effectiveness of
those controls.

this assessment, management identified material weaknesses in our internal control over financial reporting ("ICFR")
related to a material adjustment identified during the audit process indicating that controls over the financial statement close and
review process were not operating effectively to prevent or detect misstatements on a timely basis. A material
weakness is a deficiency, or a combination of deficiencies, in ICFR, such that there is a reasonable possibility that a material
misstatement of the Company's financial statements will not be prevented or detected on a timely basis. Because of the
material weaknesses described above, management has concluded that our ICFR was not effective as of December 31,
2024. In 2025, we have implemented new procedures to improve our financial statement close and review
process.

 There
was no change in our internal control over financial reporting that occurred during the quarterly period ending December 31, 2024 that
has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 Item
 9B.

 Other
 Information.

 None
of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined
in Item 408(c) of Regulation S-K) during the quarterly period ending December 31, 2024.

 Item
 9C.

 Disclosures
 Regarding Foreign Jurisdictions That Prevent Inspections.

 Not

 Item
 10.

 Directors,
 Executive Officers and Corporate Governance.

 Name

 Age

 Position

 B. O'Brien

 President,
 Chief Executive Officer, Principal Financial and Accounting Officer and a Director

 John
 H. Bientjes

 Robert
 Helina

 Tom
 Fyles

 Ben
 Seaman

 David
 Fynn

B. O'Brien has served as our President, Chief Executive Officer and Principal Financial and Accounting Officer, as well as a director
since June 1998. He has been involved in the swimming pool industry since 1990, when he founded our subsidiary, Flexible Solutions Ltd.
From 1990 to 1998 Mr. O'Brien was also a teacher at Brentwood College where he was in charge of outdoor education.

 John
H. Bientjes has been a director since 2000. From 1984 to 2018, Mr. Bientjes served as the manager of the Commercial Aquatic Supplies
Division of D.B. Perks & Associates, Ltd., located in Vancouver, British Columbia, a company that markets supplies and equipment
to commercial swimming pools which are primarily owned by municipalities. Mr. Bientjes retired in 2018. Mr. Bientjes graduated in 1976
from Simon Fraser University in Vancouver, British Columbia with a Bachelor of Arts Degree in Economics and Commerce.

 Robert
T. Helina has been a director since 2011. Mr. Helina has been involved in the financial services industry for over 35 years which has
given him extensive knowledge in business, economics and finance. His specialty is in Corporate Finance and Capital Markets. Mr. Helina
holds a Bachelor of Arts degree from Trinity Western University.

 Thomas
M. Fyles has been a director since 2012. Dr. Fyles holds chemistry degrees from the University of Victoria (B.Sc. 1974) and York University
(Ph. D. 1977). Following postdoctoral work in France, he joined the Chemistry Department at the University of Victoria in 1979 where he
progressed through the academic ranks to Professor (1992), Chair (2001 – 2006; 2008), and, on his retirement, Professor Emeritus
(2017). His research program spanned analytical, synthetic, and physical chemistry with an emphasis on sensors, membranes, and water
treatment processes.

 Ben
Seaman has been a director of the Company since October 2016. Mr. Seaman has been the CEO of Eartheasy.com Sustainable Living Ltd since
2007, an international ecommerce and wholesale distribution business. His company has contributed over $1M towards clean water projects
in Kenya since 2013, has been recognized internationally by the Stockholm Challenge Award, and the Outdoor Industry Inspiration Award
in 2016. Prior to that, he worked in sales and investor relations at Flexible Solutions. Mr. Seaman graduated from the University of
Victoria with a Bachelor of Science degree in 2004. He has significant experience in launching new products, marketing, distribution
and e-commerce in both the US and Canada. He's a strong believer in the triple bottom line approach to business, giving consideration
to social and environmental issues in addition to financial performance.

 David
Fynn has been a director since 2016. Mr. David Fynn is a Canadian Chartered Professional Accountant and services individuals/companies
in many sectors including mining and commodities in his private practice. Mr. Fynn worked as a senior manager with KPMG in Canada and
Ernst & Young in the United Kingdom and Saudi Arabia. Since 1996 he has been the principal of D.A. Fynn & Associates Inc., an
accounting firm.

 Directors
are elected annually and hold office until the next annual meeting of our stockholders and until their successors are elected and qualified.
All executive offices are chosen by the board of directors and serve at the board's discretion.

 John
Bientjes, Thomas Fyles, Ben Seaman and David Fynn are independent directors as that term is defined in section 803 of the listing standards
of the NYSE American.

 Our
Audit Committee, consisting of John Bientjes, Ben Seaman and David Fynn all of whom have strong financial backgrounds, facilitates and
maintains open communications with our board of directors, senior management and our independent auditors. Our Audit Committee also serves
as an independent and objective party which monitors our financial reporting process and internal control system. In addition, our Audit
Committee reviews and appraises the efforts of our independent auditors. Our Audit Committee meets periodically with management and our
independent auditors. John Bientjes and David Fynn meet the SEC's definition of an audit committee financial expert. Each member
of the Audit Committee is "independent" as that term is defined in Section 803 of the listing standards of the NYSE American.

 Our
Compensation Committee, consisting of John Bientjes, Ben Seaman and David Fynn, establishes salary, incentive and other forms of compensation
for our Chief Executive Officer and administers our Stock Option Plan. None of our officers participated in deliberations of the compensation
committee concerning executive officer compensation. During the year ended December 31, 2024 none of our executive officers served as
a member of the compensation committee or as a director of another entity, one of whose executive officers served on our compensation
committee or as one of our directors.

 We
have adopted a Code of Ethics that applies to our Chief Executive Officer, our Chief Financial Officer and our Principal Accounting Officer,
as well as our other senior management and financial staff. Interested persons may obtain a copy of our Code of Ethics from our website
at www.flexiblesolutions.com.

 We
believe our directors benefit us for the following reasons:

 Name

 Reason

 B. O'Brien

 Long
 standing relationship with us.

 John
 J. Bientjes

 Long
 standing relationship with us.

 Robert
 Helina

 Corporate
 finance experience.

 Dr.
 Thomas Fyles

 Scientific
 expertise.

 Ben
 Seaman

 Younger
 generation businessman increases our awareness of internet sales and adds value to our audit and compensation committees

 David
 Fynn

 Experienced
 accountant adds value to our audit and compensation committees

 Item
 11.

 Executive
 Compensation.

 Summary
Compensation Table

 The
following table shows in summary form the compensation earned by (i) our Chief Executive Officer and (ii) by each other executive officer
who earned in excess of $100,000 during the two fiscal years ended December 31, 2024.

 Name and Principal Position

 Fiscal Year

 Salary (1)

 Bonus (2)

 Restricted Stock Awards (3)

 Options Awards (4)

 All Other Annual Compensation (5)

 Total

 2024

 $
 600,000

 —

 —

 $
 316,000

 —

 $
 916,000

 President, Chief Executive Financial and Accounting Officer

 2023

 $
 785,368

 —

 —

 $
 (660,000
)

 —

 $
 125,368

 (1)

 The
 dollar value of base salary (cash and non-cash) earned.

 (2)

 The
 dollar value of bonus (cash and non-cash) earned.

 (3)

 the periods covered by the table, the value of the shares of restricted stock issued as compensation for services to the persons
 listed in the table.

 (4)

 The
 value of all stock options granted during the periods covered by the table. The options granted to Daniel O'Brien in 2022 were
 cancelled in 2023.

 (5)

 All
 other compensation received that we could not properly report in any other column of the table.

the year ended December 31, 2012, the Company determined that Daniel B. O'Brien, the Company's President and Chief Executive
Officer, was underpaid. Accordingly, the Company increased Mr. O'Brien's annual salary to twice that which was paid to the
highest paid employee of the Company. Mr. O'Brien requested his salary be dropped by $100,000/year during 2019 and the Compensation
committee agreed.

 In
the fall of 2023, Daniel O'Brien, CEO, relocated to Grand Cayman in order to help with international sales. He requested that his
salary be reduced to a flat $600,000 per year with annual increases at the same rate as other employees receive. The compensation committee
agreed and granted Mr. O'Brien's request.

 Non-Qualified
Stock Option Plan

 In
August 2014 we adopted a Non-Qualified Stock Option Plan which authorizes the issuance of up to 1,500,000 shares of our common stock
to persons that exercise options granted pursuant to the Plan. Our employees, directors and officers, and consultants or advisors are
eligible to be granted options pursuant to the Non-Qualified Plan.

 The
Plan is administered by our Compensation Committee. The Committee is vested with the authority to determine the number of shares issuable
upon the exercise of the options, the exercise price and expiration date of the options, and when, and upon what conditions options granted
under the Plan will vest or otherwise be subject to forfeiture and cancellation.

the fiscal year ended December 31, 2024 we issued nil options pursuant to the Non-Qualified Plan (2023 – nil).

 As
of December 31, 2024, options to purchase 233,000 shares of our common stock were outstanding under our Non-Qualified Stock Option Plan.
The exercise price of these options varies between $2.44 and $3.61 per share and the options expire at various dates between on December
31, 2024 and December 31, 2026.

 Stock
Option Plans

 In
2022 we adopted a Stock Incentive Plan which authorizes the issuance of up to 1,500,000 shares of our common stock to persons that exercise
options granted pursuant to the Plan. We have amended the plan in 2025 for issuance up to 2,500,000 shares of our common stock to pursuant
to the Plan. Our employees, directors and officers, and consultants or advisors are eligible to be granted options pursuant to the Stock
Incentive Plan.

 The
Plan is administered by our Compensation Committee. The Committee is vested with the authority to determine the number of shares issuable
upon the exercise of the options, the exercise price and expiration date of the options, and when, and upon what conditions options granted
under the Plan will vest or otherwise be subject to forfeiture and cancellation.

the fiscal year ended December 31, 2024 we issued 1,081,000 options pursuant to the Stock Incentive Plan (2023 – nil).

 As
of December 31, 2024, options to purchase 1,607,000 shares of our common stock were outstanding under our Stock Incentive Plan. The exercise
price of these options varies between $2.00 and $4.05 and the options expire at various dates between December 31, 2027 and December
31, 2029.

 Summary

 The
following table shows the weighted average exercise price of the outstanding options granted pursuant to both our Non-Qualified Stock
Option Plan and Stock Incentive Plan as of December 31, 2024, our most recently completed fiscal year.

 Plan Category

 Number of Securities
 to be Issued Upon
 Exercise
 of
 Outstanding Options,
 Warrants and Rights

 Weighted-Average
 Exercise Price of
 Outstanding
 Options,
 Warrants and Rights

 Number of Securities
 Remaining Available for
 Future
 Issuance Under
 Equity Compensation
 Plans (Excluding
 Securities Reflected
 in Column (a))

 (a)

 (b)

 (c)

 Non-Qualified Stock Option Plan

 233,000

 $
 3.04

 57,000

 Stock Incentive Plan

 1,607,000

 $
 2.63

 457,000

 Both
our Non-Qualified Stock Option Plan and Stock Incentive Plan have been approved by our shareholders.

 No
options were exercised by our executive officers during the fiscal year ended December 31, 2024.

Compensation

 We
reimburse directors for any expenses incurred in attending board meetings. We also compensate directors $6,000 annually for each year
that they serve with an additional $4,000 paid to the head of the Audit Committee -

 Our
directors received the following compensation in 2024:

 Name

 Paid in Cash

 Stock Awards (1)

 Option Awards (2)

 John H. Bientjes

 $
 10,000

 —

 —

 Robert Helina

 $
 6,000

 Tom Fyles

 $
 6,000

 —

 —

 Ben Seaman

 $
 6,000

 —

 —

 David Fynn

 $
 6,000

 —

 —

 (1)

 The
 fair value of stock issued for services computed in accordance with ASC 718 on the date of grant.

 (2)

 The
 fair value of options granted computed in accordance with ASC 718 on the date of grant.

B. O'Brien was not compensated for serving as a director during 2024.

 Insider
Trading Arrangements and Policies

 We
are committed to promoting high standards of ethical business conduct and compliance with applicable laws, rules and regulations. As
part of this commitment, we have adopted our Insider Trading Policy governing the purchase, sale, and/or other dispositions of our securities
by our directors, officers, employees and others that we believe is reasonably designed to promote compliance with insider trading laws,
rules and regulations. A copy of our Insider Trading Policy is filed as Exhibit 19 to this Annual Report on Form 10-K.

 Item
 12.

 Security
 Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 The
following table shows the beneficial ownership of our common stock as of March 31, 2025 by (i) each stockholder who is known by us to
own beneficially more than five percent of our outstanding common stock, (ii) each of our officers and directors, and (iii) by all of
our executive officers and directors as a group.

 Shares (1)

 Percentage Ownership

 4,430,156

 35.0
 %

 6001 54 Ave.

 Taber, AB

 Canada T1G 1X4

 John Bientjes

 %

 46081 Greenwood Dr.

 Chilliwack, BC

 Canada V2R 4C9

 Robert Helina

 35,000

 0.3
 %

 6001 54 Ave.

 Taber, AB

 Canada T1G 1X4

 Dr. Thomas Fyles

 20,000

 0.2
 %

 Box 3065

 Victoria, BC

 Canada V8W 3V6

 Ben Seaman

 %

 Unit 605 5 E. Cordova St.

 Vancouver BC

 Canada V6A 0A5

 David Fynn

 %

 202-2526 Yale Court,

 Abbotsford, BC

 Canada V2S 8G9

 All officers and directors

 as a group (6 persons)

 4,485,156

 35.5
 %

 Other Principal Shareholders

 Comprehensive Financial Planning, Inc.

 1,258,521

 10.0
 %

 (1)

 Includes
 shares which may be acquired on the exercise of the stock options, all of which were exercisable as of March 31, 2025, listed below.

 Name

 No. of Options

 Exercise Price

 Expiration Date

 $
 2.00

 December 31, 2028

 Robert Helina

 5,000

 $
 2.44

 December 31, 2025

 5,000

 $
 3.61

 December 31, 2026

 5,000

 $
 3.55

 December 31, 2027

 5,000

 $
 3.55

 December 31, 2027

 5,000

 $
 2.00

 December 31, 2028

 10,000

 $
 2.00

 July 1, 2029

 Item
 13.

 Certain
 Relationships and Related Transactions, Director Independence.

 Not

 Item
 14.

 Principal
 Accountant Fees and Services.

 Assure
CPA, LLC audited our consolidated financial statements for the year ended December 31, 2024. Smythe LLP examined our consolidated financial
statements for the year ended December 31, 2023.

 Audit
Fees

 Assure
CPA, LLC was paid $5,475 in the fiscal year ended December 31, 2024 for professional services rendered in the audit of our financial
statements. Smythe LLP was paid $152,354 in the fiscal year ended December 31, 2024 for professional services rendered in the audit of
our 2023 annual financial statements and for the reviews of the 2024 condensed interim financial statements included in our quarterly
reports on Form 10-Q during that fiscal year. Smythe LLP was paid $127,487 for professional services rendered in the audit of our annual
financial statements and for the reviews of the condensed interim financial statements included in our quarterly reports on Form 10-Q
during fiscal 2023.

 Tax
Fees

 Smythe
LLP has been retained to file our taxes for the fiscal years ended December 31, 2017 through to December 31, 2023. Smythe LLP was paid
$25,662 in the fiscal year ended December 31, 2024 (2023 – $14,079) for professional services rendered in preparing our taxes.

 All
Other Fees

 Assure
CPA, LLC and Smythe LLP were not paid any other fees for professional services during the fiscal years ended December 31, 2024 and 2023.

 Audit
Committee Pre-Approval Policies

 Rules
adopted by the SEC in order to implement requirements of the Sarbanes-Oxley Act of 2002 require public company audit committees to pre-approve
audit and non-audit services. Our Audit Committee has adopted a policy for the pre-approval of all audit, audit-related and tax services,
and permissible non-audit services provided by our independent auditors. The policy provides for an annual review of an audit plan and
budget for the upcoming annual financial statement audit, and entering into an engagement letter with the independent auditors covering
the scope of the audit and the fees to be paid. Our Audit Committee may also from time-to-time review and approve in advance other specific
audit, audit-related, tax or permissible non-audit services. In addition, our Audit Committee may from time-to-time give pre-approval
for audit services, audit-related services, tax services or other non-audit services by setting forth such pre-approved services on a
schedule containing a description of, budget for, and time period for such pre-approved services. The policy requires our Audit Committee
to be informed of each service and the policies do not include any delegation of our Audit Committee's responsibilities to management.
Our Audit Committee may delegate pre-approval authority to one or more of its members. The member to whom such authority is delegated
will report any pre-approval decisions to our Audit Committee at its next scheduled meeting.

the year ended December 31, 2024 our Audit Committee approved all of the fees paid to Assure CPA, LLC and Smythe LLP. Our Audit Committee
has determined that the rendering of all non-audit services by Assure CPA, LLC and Smythe LLP is compatible with maintaining its independence.

 Item
 15.

 Exhibits,
 Financial Statement Schedules.

 Number

 Description

 3.1

 Articles of Incorporation of the Registrant. (1)

 3.2

 Bylaws of the Registrant. (1)

 Insider Trading Policy and Procedures

 21.1

 Subsidiaries. (2)

 23.1

 Consent of Independent Accountants.

 31.1

 Certification of Principal Executive Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

 31.2

 Certification of Principal Financial Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

 32.1

 Certification of Principal Executive and Financial Officer Pursuant to 18 U.S.C. §1350 and §906 of the Sarbanes-Oxley Act of 2002.

 101.INS

 101.SCH

 101.CAL

 101.DEF

 101.LAB

 101.PRE

 Cover

 (1)

 Previously
 filed as an exhibit to our Registration Statement on Form 10-SB filed with the Commission on February 22, 2000, and incorporated
 herein by reference.

 (2)

 Previously
 filed as an exhibit to our Registration Statement on Form SB-2 filed with the Commission on January 22, 2003, and incorporated herein
 by reference.

 SIGNATURES

 In
accordance with the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.

 March

 Flexible
 Solutions International, Inc.

 By:

 /s/

 Name:

 B. O'Brien

 Title:

 President
 and Chief Executive Officer

 In
accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities
and on the dates indicated:

 Signature

 Title

 Date

 /s/

 President,
Principal Executive Officer,

 March

 B. O'Brien

 Principal Financial and Accounting Officer and a Director

 /s/
 John H. Bientjes

 March

 John
 H. Bientjes

 /s/
 Robert T. Helina

 March

 Robert
 T. Helina

 /s/
 Thomas Fyles

 March

 Thomas
 Fyles

 /s/
 Ben Seaman

 March

 Ben
 Seaman

 /s/
 David Fynn

 March

 David
 Fynn